Document:

Exhibit 10.1

 

EXECUTION VERSION

 

STANDBY EQUITY PURCHASE AGREEMENT

 

THIS STANDBY EQUITY PURCHASEAGREEMENT
(this “Agreement”) dated as of May 13, 2022 is made by and between YA II PN, LTD., a Cayman Islands
exempt limited partnership (the “Investor”), and KULR TECHNOLOGY GROUP, INC., a company incorporated under
the laws of the State of Delaware (the “Company”).

 

WHEREAS, the parties
desire that, upon the terms and subject to the conditions contained herein, the Company shall have the right to issue and sell to the
Investor, from time to time as provided herein, and the Investor shall purchase from the Company, up to $50 million of the Company’s
shares of common stock, par value $0.0001 per share (the “Common Shares”); and

 

WHEREAS, the Common
Shares are listed for trading on the NYSE American Market under the symbol “KULR” and

 

WHEREAS, the offer
and sale of the Common Shares issuable hereunder will be made in reliance upon Section 4(a)(2) under the Securities Act of 1933,
as amended, and the rules and regulations promulgated thereunder (the “Securities Act”), or upon such other exemption
from the registration requirements of the Securities Act as may be available with respect to any or all of the transactions to be made
hereunder.

 

NOW, THEREFORE,
the parties hereto agree as follows:

 

Article I. Certain Definitions

 

Section 1.01     “Additional
Shares” shall have the meaning set forth in Section 2.01(d)(ii).

 

Section 1.02     “Adjusted
Advance Amount” shall have the meaning set forth in Section 2.01(d)(i).

 

Section 1.03     “Advance
Date” shall mean the 1st Trading Day after expiration of the applicable Pricing Period for each Advance.

 

Section 1.04     “Advance
Notice” shall mean a written notice in the form of Exhibit A attached hereto to the Investor executed by an officer of
the Company and setting forth the amount of an Advance that the Company desires to issue and sell to the Investor.

 

Section 1.05     “Advance
Notice Date” shall mean each date the Company delivers (in accordance with Section 2.01(b) of this Agreement) to the
Investor an Advance Notice, subject to the terms of this Agreement.

 

Section 1.06     “Advance
Shares” shall mean the number of Common Shares that the Company desires to issue and sell to the Investor as requested by the
Company in an Advance Notice.

 

     

     

    

 

Section 1.07     “Advances”
shall mean any issuance and sale from the Company to the Investor pursuant to Article II hereof.

 

Section 1.08     “Affiliate”
shall have the meaning set forth in Section 3.06.

 

Section 1.09     “Agreement”
shall have the meaning set forth in the preamble of this Agreement.

 

Section 1.10     “Applicable
Laws” shall mean all applicable laws, statutes, rules, regulations, orders, executive orders, directives, policies, guidelines
and codes having the force of law, whether local, national, or international, as amended from time to time, including without limitation
(i) all applicable laws that relate to money laundering, terrorist financing, financial record keeping and reporting, (ii) all
applicable laws that relate to anti-bribery, anti-corruption, books and records and internal controls, including the United States Foreign
Corrupt Practices Act of 1977, and (iii) any Sanctions laws.

 

Section 1.11     “Basket”
shall have the meaning set forth in Section 5.04.

 

Section 1.12     “Black
Out Period” shall have the meaning set forth in Section 6.02(a)

 

Section 1.13     “Closing”
shall have meaning set forth in Section 2.02.

 

Section 1.14     “Commitment
Amount” shall mean $50,000,000 of Common Shares, provided that, the Company shall not affect any sales under this Agreement
and the Investor shall not have the obligation to purchase Common Shares under this Agreement to the extent (but only to the extent) that
after giving effect to such purchase and sale the aggregate number of Common Shares issued under this Agreement would exceed 19.9% of
the outstanding Common Shares as of the date of this Agreement (the “Exchange Cap”) provided further that, the
Exchange Cap will not apply if (a) the Company’s stockholders have approved issuances in excess of the Exchange Cap in accordance
with the rules of the Principal Market or (b) the average price of all applicable sales of Common Shares hereunder equals or
exceeds $1.22 per share (which represents the lower of (i) the NYSE American
Official Closing Price (as reflected on Bloomberg, LP) immediately preceding the signing of this Agreement; or (ii) the average NYSE
American Official Closing Price of the Common Shares (as reflected on Bloomberg, LP) for the five trading days immediately preceding the
signing of this Agreement).

 

Section 1.15     “Commitment
Period” shall mean the period commencing on the date hereof and expiring upon the date of termination of this Agreement in accordance
with Section 11.02.

 

Section 1.16     “Common
Shares” shall have the meaning set forth in the recitals of this Agreement.

 

Section 1.17     “Company”
shall have the meaning set forth in the preamble of this Agreement.

 

Section 1.18     “Company
Indemnitees” shall have the meaning set forth in Section 5.02.

 

Section 1.19     “Condition
Satisfaction Date” shall have the meaning set forth in Section 7.01.

 

    - 2 -

     

    

 

Section 1.20     “Environmental
Laws” shall have the meaning set forth in Section 4.13.

 

Section 1.21     “Exchange
Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

 

Section 1.22     “Exchange
Cap” shall have the meaning set forth in Section 1.12

 

Section 1.23     “Hazardous
Materials” shall have the meaning set forth in Section 4.13.

 

Section 1.24     “Indemnified
Liabilities” shall have the meaning set forth in Section 5.01.

 

Section 1.25     “Investor”
shall have the meaning set forth in the preamble of this Agreement.

 

Section 1.26     “Investor
Indemnitees” shall have the meaning set forth in Section 5.01.

 

Section 1.27     “Market
Price” shall mean the lowest daily VWAP of the Common Shares during the relevant Pricing Period.

 

Section 1.28     “Material
Adverse Effect” shall mean any event, occurrence or condition that has had or would reasonably be expected to have (i) a
material adverse effect on the legality, validity or enforceability of this Agreement or the transactions contemplated herein, (ii) a
material adverse effect on the results of operations, assets, business or condition (financial or otherwise) of the Company and its Subsidiaries,
taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely
basis its obligations under this Agreement.

 

Section 1.29     “Material
Outside Event” shall have the meaning set forth in Section 6.08.

 

Section 1.30     “Maximum
Advance Amount” up to $5,000,000 or such other amount as is mutually agreed by the Company and the Investor.

 

Section 1.31     “Minimum
Acceptable Price” or “MAP” shall mean the minimum price notified by the Company to the Investor in each Advance
Notice, if applicable.

 

Section 1.32     “OFAC”
shall mean the U.S. Department of Treasury’s Office of Foreign Asset Control.

 

Section 1.33     “Ownership
Limitation” shall have the meaning set forth in Section 2.01(c)(i).

 

Section 1.34     “Person”
shall mean an individual, a corporation, a partnership, a limited liability company, a trust or other entity or organization, including
a government or political subdivision or an agency or instrumentality thereof.

 

Section 1.35     “Plan
of Distribution” shall mean the section of a Registration Statement disclosing the plan of distribution of the Shares.

 

    - 3 -

     

    

 

Section 1.36     “Pricing
Period” shall mean the three (3) consecutive Trading Days, or such less number of consecutive Trading Days as is mutually
agreed by the Company and the Investor, commencing on the Advance Notice Date.

 

Section 1.37     “Principal
Market” shall mean the New York Stock Exchange, NYSE American, the Nasdaq Global Select Market, the Nasdaq Global Market, the
Nasdaq Capital Market, the OTCBB, or the NYSE Euronext, whichever is at the time the principal trading exchange or market for the Common
Shares.

 

Section 1.38     “Prospectus”
means any prospectus (including, without limitation, all amendments and supplements thereto) used in connection with a Registration Statement.

 

Section 1.39     “Prospectus
Supplement” shall mean any prospectus supplement to a Prospectus filed with the SEC pursuant to Rule 424(b) under
the Securities Act, including, without limitation, any Prospectus Supplement to be filed in accordance with Section 6.01 hereof.

 

Section 1.40     “Purchase
Price” shall mean the price per Share obtained by multiplying the Market Price by 98%.

 

Section 1.41     “Registrable
Securities” shall mean (i) the Shares, and (ii) any securities issued or issuable with respect to any of the foregoing
by way of exchange, stock dividend or stock split or in connection with a combination of shares, recapitalization, merger, consolidation
or other reorganization or otherwise.

 

Section 1.42     “Registration
Limitation” shall have the meaning set forth in Section 2.01(c)(ii).

 

Section 1.43     “Registration
Statement” shall mean a registration statement on Form S-1 or Form S-3 or on such other form promulgated by the SEC
for which the Company then qualifies and which counsel for the Company shall deem appropriate, and which form shall be available for the
registration of the offer and sale to, and resale by the Investor of the Registrable Securities under the Securities Act.

 

Section 1.44     “Regulation
D” shall mean the provisions of Regulation D promulgated under the Securities Act.

 

Section 1.45     “Sanctions”
means any sanctions administered or enforced by OFAC, the U.S. State Department, the United Nations Security Council, the European Union,
Her Majesty’s Treasury, or other relevant sanctions authority.

 

Section 1.46     “Sanctions
Programs” means any OFAC economic sanction program (including, without limitation, programs related to Crimea, Cuba, Iran,
North Korea, Sudan and Syria).

 

Section 1.47     “SEC”
shall mean the U.S. Securities and Exchange Commission.

 

Section 1.48     “SEC
Documents” shall have the meaning set forth in Section 4.05.

 

Section 1.49     “Securities
Act” shall have the meaning set forth in the recitals of this Agreement.

 

    - 4 -

     

    

 

Section 1.50     “Settlement
Document” shall have the meaning set forth in Section 2.02(a).

 

Section 1.51     “Shares”
shall mean the Common Shares to be issued from time to time hereunder pursuant to an Advance.

 

Section 1.52     “Subsidiaries”
shall have the meaning set forth in Section 4.01.

 

Section 1.53     “Trading
Day” shall mean any day during which the Principal Market shall be open for business.

 

Section 1.54     “Transaction
Documents” shall have the meaning set forth in Section 4.02.

 

Section 1.55     “VWAP”
means, for any Trading Day, the daily volume weighted average price of the Common Shares for such Trading Day on the Principal Market
during regular trading hours as reported by Bloomberg L.P.

 

Article II. Advances

 

Section 2.01     Advances;
Mechanics. Subject to the terms and conditions of this Agreement (including, without limitation, the provisions of Article VII
hereof), the Company, at its sole and exclusive option, may issue and sell to the Investor, and the Investor shall purchase from the Company,
Common Shares on the following terms:

 

		(a)	Advance Notice. At any time during the Commitment Period the Company may require the Investor to
purchase Shares by delivering an Advance Notice to the Investor, subject to the conditions set forth in Section 7.01, and in accordance
with the following provisions:

 

		(i)	The Company shall, in its sole discretion, select the amount of the Advance, not to exceed the Maximum
Advance Amount and as may be adjusted upon mutual agreement of the parties, it desires to issue and sell to the Investor in each Advance
Notice and the time it desires to deliver each Advance Notice.

 

		(ii)	There shall be no mandatory minimum Advances and no non-usages fee for not utilizing the Commitment Amount
or any part thereof.

 

		(b)	Date of Delivery of Advance Notice.
                                            Advance Notices shall be delivered in accordance with the instructions set forth on the bottom
                                            of Exhibit A. An Advance Notice shall be deemed delivered on (i) the day
                                            it is received by the Investor if such notice is received by email prior on or before 8:30
                                            a.m. Eastern Time (or later if waived by the Investor in its sole discretion) in accordance
                                            with the instructions set forth on the bottom of Exhibit A, or (ii) the immediately
                                            succeeding day if it is received by email after 8:30 a.m. Eastern Time, in each case
                                            in accordance with the instructions set forth on the bottom of Exhibit A.

 

    - 5 -

     

    

 

		(c)	Advance Limitations. Regardless of the amount of an Advance requested by the Company in the Advance
Notice, the final number of Shares to be issued and sold pursuant to an Advance Notice shall be reduced in accordance with each of the
following limitations:

 

		(i)	Ownership Limitation; Commitment Amount. In no event shall the number of Common Shares issuable
to the Investor pursuant to an Advance cause the aggregate number of Common Shares beneficially owned (as calculated pursuant to Section 13(d) of
the Exchange Act) by the Investor and its Affiliates as a result of previous issuances and sales of Common Shares to Investor under this
Agreement to exceed 4.99% of the then outstanding Common Shares (the “Ownership Limitation”). In connection with each
Advance Notice delivered by the Company, any portion of the Advance that would (i) cause the Investor to exceed the Ownership Limitation
or (ii) cause the aggregate number of Shares issued and sold to the Investor hereunder to exceed the Commitment Amount shall automatically
be withdrawn with no further action required by the Company, and such Advance Notice shall be deemed automatically modified to reduce
the amount of the Advance requested by an amount equal to such withdrawn portion; provided that in the event of any such automatic withdrawal
and automatic modification, Investor will promptly notify the Company of such event.

 

		(ii)	Registration Limitation. In no event shall an Advance exceed the amount registered under the Registration
Statement then in effect (the “Registration Limitation”) or the Exchange Cap, to the extent applicable. In connection
with each Advance Notice, any portion of an Advance that would exceed the Registration Limitation or the Exchange Cap shall automatically
be withdrawn with no further action required by the Company and such Advance Notice shall be deemed automatically modified to reduce the
aggregate amount of the requested Advance by an amount equal to such withdrawn portion in respect of each Advance Notice; provided that
in the event of any such automatic withdrawal and automatic modification, Investor will promptly notify the Company of such event.

 

		(d)	Minimum Acceptable Price.

 

		(i)	With respect to each Advance Notice, the Company may notify the Investor of the MAP with respect to such
Advance by indicating a MAP on such Advance Notice. If no MAP is specified in an Advance Notice, then no MAP shall be in effect in connection
with such Advance. Each Trading Day during a Pricing Period for which (A) with respect to each Advance Notice with a MAP, the VWAP
of the Common Shares is below the Minimum Acceptable Price in effect with respect to such Advance Notice, or (B) there is no VWAP
(each such day, an “Excluded Day”), shall result in an automatic reduction to the amount of the Advance set forth in
such Advance Notice by 20% (the resulting amount of each Advance being the “Adjusted Advance Amount”), and each Excluded
Day shall be excluded from the Pricing Period for purposes of determining the Market.

 

    - 6 -

     

    

 

		(ii)	The total Shares in respect of each Advance (after reductions have been made to arrive at the Adjusted
Advance Amount) shall be automatically increased by such number of Common Shares (the “Additional Shares”) equal to
the number of Common Shares sold by the Investor on such Excluded Day, if any, and the price paid per share for each Additional Share
shall be equal to the MAP in effect with respect to such Advance Notice (without any further discount), provided that this increase shall
not cause the total Advance Shares to exceed the amount set forth in the original Advance Notice or any limitations set forth in Section 2.01(c).

 

		(e)	Notwithstanding any other provision in this Agreement, the Company and the Investor acknowledge and agree
that upon the Investor’s receipt of a valid Advance Notice the parties shall be deemed to have entered into an unconditional contract
binding on both parties for the purchase and sale of Shares pursuant to such Advance Notice in accordance with the terms of this Agreement
and (i) subject to Applicable Law and (ii) subject to Section 3.08 (Trading Activities), the Investor may sell Common Shares
during the Pricing Period.

 

Section 2.02     Closings.
The closing of each Advance and each sale and purchase of Advance Shares (each, a “Closing”) shall take place as soon
as practicable on or after each Advance Date in accordance with the procedures set forth below. The parties acknowledge that the Purchase
Price is not known at the time the Advance Notice is delivered (at which time the Investor is irrevocably bound) but shall be determined
on each Closing based on the daily prices of the Common Shares that are the inputs to the determination of the Purchase Price as set forth
further below. In connection with each Closing, the Company and the Investor shall fulfill each of its obligations as set forth below:

 

		(a)	On each Advance Date, the Investor shall deliver to the Company a written document, in the form attached
hereto as Exhibit B (each a “Settlement Document”), setting forth the final number of Shares to be purchased by
the Investor (taking into account any adjustments pursuant to Section 2.01), the Market Price, the Purchase Price, the aggregate
proceeds to be paid by the Investor to the Company, and a report by Bloomberg, L.P. indicating the VWAP for each of the Trading Days during
the Pricing Period (or, if not reported on Bloomberg, L.P., another reporting service reasonably agreed to by the parties), in each case
in accordance with the terms and conditions of this Agreement.

 

		(b)	Promptly after receipt of the Settlement Document with respect to each Advance (and, in any event, not
later than one Trading Day after such receipt), the Company will, or will cause its transfer agent to, electronically transfer such number
of Shares to be purchased by the Investor (as set forth in the Settlement Document) by crediting the Investor’s account or its designee’s
account at the Depository Trust Company through its Deposit Withdrawal at Custodian System or by such other means of delivery as may be
mutually agreed upon by the parties hereto, and transmit notification to the Investor that such share transfer has been requested. Promptly
upon receipt of such notification, the Investor shall pay to the Company the aggregate purchase price of the Shares (as set forth in the
Closing Statement) in cash in immediately available funds to an account designated by the Company in writing and transmit notification
to the Company that such funds transfer has been requested. No fractional shares shall be issued, and any fractional amounts shall be
rounded to the next higher whole number of shares. To facilitate the transfer of the Common Shares by the Investor, the Common Shares
will not bear any restrictive legends so long as there is an effective Registration Statement covering such Common Shares (it being understood
and agreed by the Investor that notwithstanding the lack of restrictive legends, the Investor may only sell such Common Shares pursuant
to the Plan of Distribution set forth in the prospectus included in the Registration Statement and otherwise in compliance with the requirements
of the Securities Act (including any applicable prospectus delivery requirements) or pursuant to an available exemption).

 

    - 7 -

     

    

 

		(c)	On or prior to the Advance Date, each of the Company and the Investor shall deliver to the other all documents,
instruments and writings expressly required to be delivered by either of them pursuant to this Agreement in order to implement and effect
the transactions contemplated herein.

 

		(d)	Notwithstanding anything to the contrary in this Agreement, if on any day during the Pricing Period (i) the
Company notifies Investor that a Material Outside Event has occurred, or (ii) the Company notifies the Investor of a Black Out Period,
the parties agree that the pending Advance shall end and the final number of Shares to be purchased by the Investor at the Closing for
such Advance shall be equal to the number of Common Shares sold by the Investor during the applicable Pricing Period prior to the notification
from the Company of a Material Outside Event or Black Out Period.

 

Section 2.03     Hardship.

 

		(a)	In the event the Investor sells Common Shares of the Company after receipt of an Advance Notice and the
Company fails to perform its obligations as mandated in Section 2.02, the Company agrees that in addition to and in no way limiting
the rights and obligations set forth in Article V hereto and in addition to any other remedy to which the Investor is entitled at
law or in equity, including, without limitation, specific performance, it will hold the Investor harmless against any loss, claim, damage,
or expense (including reasonable legal fees and expenses), as incurred, arising out of or in connection with such default by the Company
and acknowledges that irreparable damage may occur in the event of any such default. It is accordingly agreed that the Investor shall
be entitled to an injunction or injunctions to prevent such breaches of this Agreement and to specifically enforce (subject to the Securities
Act and other rules of the Principal Market), without the posting of a bond or other security, the terms and provisions of this Agreement.

 

		(b)	In the event the Company provides an Advance Notice and the Investor fails to perform its obligations
as mandated in Section 2.02, the Investor agrees that in addition to and in no way limiting the rights and obligations set forth
in Article V hereto and in addition to any other remedy to which the Company is entitled at law or in equity, including, without
limitation, specific performance, it will hold the Company harmless against any loss, claim, damage, or expense (including reasonable
legal fees and expenses), as incurred, arising out of or in connection with such default by the Investor and acknowledges that irreparable
damage may occur in the event of any such default. It is accordingly agreed that the Company shall be entitled to an injunction or injunctions
to prevent such breaches of this Agreement and to specifically enforce (subject to the Securities Act and other rules of the Principal
Market), without the posting of a bond or other security, the terms and provisions of this Agreement.

 

    - 8 -

     

    

 

Section 2.04     Completion
of Resale Pursuant to the Registration Statement. After the Investor has purchased the full Commitment Amount and has completed the
subsequent resale of the full Commitment Amount pursuant to the Registration Statement, Investor will notify the Company that all
subsequent resales are completed and the Company will be under no further obligation to maintain the effectiveness of the Registration
Statement.

 

Article III. Representations and Warranties
of Investor

 

Investor hereby represents
and warrants to, and agrees with, the Company that the following are true and correct as of the date hereof and as of each Advance Notice
Date and each Advance Date:

 

Section 3.01     Organization
and Authorization. The Investor is duly organized, validly existing and in good standing under the laws of the Cayman Islands and
has all requisite power and authority to execute, deliver and perform this Agreement, including all transactions contemplated hereby.
The decision to invest and the execution and delivery of this Agreement by the Investor, the performance by the Investor of its obligations
hereunder and the consummation by the Investor of the transactions contemplated hereby have been duly authorized and require no other
proceedings on the part of the Investor. The undersigned has the right, power and authority to execute and deliver this Agreement and
all other instruments on behalf of the Investor or its shareholders. This Agreement has been duly executed and delivered by the Investor
and, assuming the execution and delivery hereof and acceptance thereof by the Company, will constitute the legal, valid and binding obligations
of the Investor, enforceable against the Investor in accordance with its terms.

 

Section 3.02     Evaluation
of Risks. The Investor has such knowledge and experience in financial, tax and business matters as to be capable of evaluating the
merits and risks of, and bearing the economic risks entailed by, an investment in the Common Shares of the Company and of protecting its
interests in connection with the transactions contemplated hereby. The Investor acknowledges and agrees that its investment in the Company
involves a high degree of risk, and that the Investor may lose all or a part of its investment.

 

Section 3.03     No
Legal, Investment or Tax Advice from the Company. The Investor acknowledges that it had the opportunity to review this Agreement
and the transactions contemplated by this Agreement with its own legal counsel and investment and tax advisors. The Investor is relying
solely on such counsel and advisors and not on any statements or representations of the Company or any of the Company’s representatives
or agents for legal, tax, investment or other advice with respect to the Investor’s acquisition of Common Shares hereunder, the
transactions contemplated by this Agreement or the laws of any jurisdiction, and the Investor acknowledges that the Investor may lose
all or a part of its investment.

 

    - 9 -

     

    

 

Section 3.04     Investment
Purpose. The Investor is acquiring the Common Shares for its own account, for investment purposes and not with a view towards, or
for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered under or exempt from the registration
requirements of the Securities Act; provided, however, that by making the representations herein, the Investor does not agree,
or make any representation or warranty, to hold any of the Securities for any minimum or other specific term and reserves the right to
dispose of the Securities at any time in accordance with, or pursuant to, a Registration Statement filed pursuant to this Agreement or
an applicable exemption under the Securities Act. The Investor does not presently have any agreement or understanding, directly or indirectly,
with any Person to sell or distribute any of the Common Shares. The Investor acknowledges that it
will be disclosed as an “underwriter” and a “selling stockholder” in each Registration Statement and in any prospectus
contained therein.

 

Section 3.05     Accredited
Investor. The Investor is an “Accredited Investor” as that term is defined in Rule 501(a)(3) of Regulation
D.

 

Section 3.06     Information.
The Investor and its advisors (and its counsel), if any, have been furnished with all materials relating to the business, finances and
operations of the Company and information the Investor deemed material to making an informed investment decision. The Investor and its
advisors (and its counsel), if any, have been afforded the opportunity to ask questions of the Company and its management and have received
answers to such questions. Neither such inquiries nor any other due diligence investigations conducted by such Investor or its advisors
(and its counsel), if any, or its representatives shall modify, amend or affect the Investor’s right to rely on the Company’s
representations and warranties contained in this Agreement. The Investor acknowledges and agrees that the Company has not made to the
Investor, and the Investor acknowledges and agrees it has not relied upon, any representations and warranties of the Company, its employees
or any third party other than the representations and warranties of the Company contained in this Agreement. The Investor understands
that its investment involves a high degree of risk. The Investor has sought such accounting, legal and tax advice, as it has considered
necessary to make an informed investment decision with respect to the transactions contemplated hereby.

 

Section 3.07     Not
an Affiliate. The Investor is not an officer, director or a person that directly, or indirectly through one or more intermediaries,
controls or is controlled by, or is under common control with the Company or any “affiliate” of the Company (as that
term is defined in Rule 405 promulgated under the Securities Act).

 

Section 3.08     Trading
Activities. The Investor’s trading activities with respect to the Common Shares shall be in compliance with all applicable
federal and state securities laws, rules and regulations and the rules and regulations of the Principal Market. Neither the
Investor nor its affiliates has any open short position in the Common Shares, and the Investor agrees that it shall not, and that it
will cause its affiliates not to, engage in any short sales with respect to the Common Shares; provided that the Company acknowledges
and agrees that (a) the Investor may engage in the trading of options with respect to the Common Shares, (b) upon receipt of
an Advance Notice the Investor has the right to sell (i) the Shares to be issued to the Investor pursuant to the Advance Notice
prior to receiving such Shares, or (ii) other Common Shares sold by the Company to Investor pursuant to this Agreement and which
the Company has continuously held as a long position.

 

    - 10 -

     

    

 

Section 3.09     General
Solicitation. Neither the Investor, nor any of its affiliates, nor any person acting on its or their behalf, has engaged or will
engage in any form of general solicitation or general advertising (within the meaning of Regulation D) in connection with any offer or
sale of the Common Shares by the Investor.

 

Article IV. Representations and Warranties
of the Company

 

Except as set forth in the
SEC Documents, or in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation
or warranty otherwise made herein to the extent of the disclosure contained in the corresponding section of the Disclosure Schedules
or in another Section of the Disclosure Schedules, to the extent that it is reasonably apparent on the face of such disclosure that
such disclosure is applicable to such Section, the Company represents and warrants to the Investor that, as of the date hereof, each
Advance Notice Date and each Advance Date (other than representations and warranties which address matters only as of a certain date,
which shall be true and correct as written as of such certain date), that:

 

Section 4.01     Organization
and Qualification. Each of the Company and its Subsidiaries (as defined below) is an entity duly organized and validly existing under
the laws of its state of organization or incorporation, and has the requisite power and authority to own its properties and to carry on
its business as now being conducted. Each of the Company and its Subsidiaries is duly qualified to do business and is in good standing
(to the extent applicable) in every jurisdiction in which the nature of the business conducted by it makes such qualification necessary,
except to the extent that the failure to be so qualified or be in good standing would not have a Material Adverse Effect. “Subsidiaries”
means any Person (as defined below) in which the Company, directly or indirectly, (x) owns any of the outstanding capital stock or
holds any equity or similar interest of such Person or (y) controls or operates all or any part of the business, operations or administration
of such Person, and each of the foregoing, is individually referred to herein as a “Subsidiary.”

 

Section 4.02     Authorization,
Enforcement, Compliance with Other Instruments. The Company has the requisite corporate power and authority to enter into and perform
its obligations under this Agreement and the other Transaction Documents and to issue the Shares in accordance with the terms hereof and
thereof. The execution and delivery by the Company of this Agreement and the other Transaction Documents, and the consummation by the
Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Common Shares) have been
or (with respect to consummation) will be duly authorized by the Company’s board of directors and no further consent or authorization
will be required by the Company, its board of directors or its shareholders. This Agreement and the other Transaction Documents to which
it is a party have been (or, when executed and delivered, will be) duly executed and delivered by the Company and, assuming the execution
and delivery thereof and acceptance by the Investor, constitute (or, when duly executed and delivered, will be) the legal, valid and binding
obligations of the Company, enforceable against the Company in accordance with their respective terms, except as such enforceability may
be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or other laws
relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies and except as rights to indemnification
and to contribution may be limited by federal or state securities law. “Transaction Documents” means, collectively,
this Agreement and each of the other agreements and instruments entered into or delivered by any of the parties hereto in connection with
the transactions contemplated hereby and thereby, as may be amended from time to time.

 

    - 11 -

     

    

 

Section 4.03     Authorization
of the Shares. The Shares to be issued under this Agreement have been, or with respect to Shares to be purchased by the Investor pursuant
to an Advance Notice, will be, when issued and delivered pursuant to the terms approved by the board of directors of the Company or a
duly authorized committee thereof, or a duly authorized executive committee, against payment therefor as provided herein, duly and validly
authorized and issued and fully paid and nonassessable, free and clear of any pledge, lien, encumbrance, security interest or other claim,
including any statutory or contractual preemptive rights, resale rights, rights of first refusal or other similar rights, and will be
registered pursuant to Section 12 of the Exchange Act. The Shares, when issued, will conform to the description thereof set forth
in or incorporated into the Prospectus.

 

Section 4.04     No
Conflict. The execution, delivery and performance of the Transaction Documents by the Company and the consummation by the Company
of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Common Shares) will not (i) result
in a violation of the articles of incorporation or other organizational documents of the Company or its Subsidiaries (with respect to
consummation, as the same may be amended prior to the date on which any of the transactions contemplated hereby are consummated), (ii) conflict
with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others
any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Company or
its Subsidiaries is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal
and state securities laws and regulations) applicable to the Company or its Subsidiaries or by which any property or asset of the Company
or its Subsidiaries is bound or affected except, in the case of clause (ii) or (iii) above, to the extent such violations that
would not reasonably be expected to have a Material Adverse Effect.

 

Section 4.05     SEC
Documents; Financial Statements. The Company has timely filed (giving effect to permissible extensions in accordance with Rule 12b-25
under the Exchange Act) all reports, schedules, forms, statements and other documents required to be filed by it with the SEC pursuant
to the Exchange Act for the two years preceding the date hereof (or such shorter period as the Company was required by law or regulation
to file such material) (all of the foregoing filed within two years preceding the date hereof or amended after the date hereof, or filed
after the date hereof, and all exhibits included therein and financial statements and schedules thereto and documents incorporated by
reference therein, and all registration statements filed by the Company under the Securities Act (including any Registration statements
filed hereunder), being hereinafter referred to as the “SEC Documents”). The Company has delivered or made available
to the Investor through the SEC’s website at http://www.sec.gov, true and complete copies of the SEC Documents. As of their respective
dates (or, with respect to any filing that has been amended or superseded, the date of such amendment or superseding filing), the SEC
Documents complied in all material respects with the requirements of the Exchange Act or the Securities Act, as applicable, and the rules and
regulations of the SEC promulgated thereunder applicable to the SEC Documents, and did not contained any untrue statement of a material
fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading.

 

    - 12 -

     

    

 

Section 4.06     Financial
Statements. The consolidated financial statements of the Company included or incorporated by reference in SEC Documents, together
with the related notes and schedules, present fairly, in all material respects, the consolidated financial position of the Company and
the Subsidiaries as of the dates indicated and the consolidated results of operations, cash flows and changes in stockholders’ equity
of the Company for the periods specified and have been prepared in compliance with the requirements of the Securities Act and Exchange
Act and in conformity with generally accepted accounting principles in the United States (“GAAP”) applied on a consistent
basis (except for (i) such adjustments to accounting standards and practices as are noted therein, (ii) in the case of unaudited
interim financial statements, to the extent such financial statements may not include footnotes required by GAAP or may be condensed or
summary statements and (iii) such adjustments which will not be material, either individually or in the aggregate) during the periods
involved; the other financial and statistical data with respect to the Company and the Subsidiaries (as defined below) contained or incorporated
by reference in the SEC Documents are accurately and fairly presented and prepared on a basis consistent with the financial statements
and books and records of the Company; there are no financial statements (historical or pro forma) that are required to be included or
incorporated by reference in the SEC Documents that are not included or incorporated by reference as required; the Company and the Subsidiaries
(as defined below) do not have any material liabilities or obligations, direct or contingent (including any off-balance sheet obligations),
not described in the SEC Documents (excluding the exhibits thereto); and all disclosures contained or incorporated by reference in the
SEC Documents regarding “non-GAAP financial measures” (as such term is defined by the rules and regulations of the Commission)
comply in all material respects with Regulation G of the Exchange Act and Item 10 of Regulation S-K under the Securities Act, to the extent
applicable. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the SEC Documents
fairly presents the information called for in all material respects and has been prepared in accordance with the SEC’s rules and
guidelines applicable thereto

 

Section 4.07     Registration
Statement and Prospectus. The Company and the transactions contemplated by this Agreement meet the requirements for and comply with
the conditions for the use of Form S-3 under the Securities Act. Each Registration Statement and the offer and sale of Shares as
contemplated hereby meet the requirements of Rule 415 under the Securities Act and comply in all material respects with said Rule.
Any statutes, regulations, contracts or other documents that are required to be described in a Registration Statement or a Prospectus,
or to be filed as exhibits to a Registration Statement have been so described or filed. Copies of each Registration Statement, any Prospectus,
and any such amendments or supplements and all documents incorporated by reference therein that were filed with the Commission on or prior
to the date of this Agreement have been delivered, or are available through EDGAR, to the Investor and its counsel. The Company has not
distributed and, prior to the later to occur of each Settlement Date and completion of the distribution of the Shares, will not distribute
any offering material in connection with the offering or sale of the Shares other than a Registration Statement and the Prospectus and
any Issuer Free Writing Prospectus (as defined below) to which the Investor has consented.

 

    - 13 -

     

    

 

Section 4.08     No
Misstatement or Omission. Each Registration Statement, when it became or becomes effective, and any Prospectus, on the date of such
Prospectus or amendment or supplement, conformed and will conform in all material respects with the requirements of the Securities Act.
At each Advance Date, the Registration Statement, and the Prospectus, as of such date, will conform in all material respects with the
requirements of the Securities Act. Each Registration Statement, when it became or becomes effective, did not, and will not, contain an
untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein not misleading. Each Prospectus did not, or will not, include an untrue statement of a material fact or omit to state a material
fact necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. The documents
incorporated by reference in a Prospectus or any Prospectus Supplement did not, and any further documents filed and incorporated by reference
therein will not, when filed with the Commission, contain an untrue statement of a material fact or omit to state a material fact required
to be stated in such document or necessary to make the statements in such document, in light of the circumstances under which they were
made, not misleading. The foregoing shall not apply to statements in, or omissions from, any such document made in reliance upon, and
in conformity with, information furnished to the Company by the Investor specifically for use in the preparation thereof.

 

Section 4.09     Conformity
with Securities Act and Exchange Act. Each Registration Statement, each Prospectus, or any amendment or supplement thereto, and the
documents incorporated by reference in each Registration Statement, Prospectus or any amendment or supplement thereto, when such documents
were or are filed with the SEC under the Securities Act or the Exchange Act or became or become effective under the Securities Act, as
the case may be, conformed or will conform in all material respects with the requirements of the Securities Act and the Exchange Act,
as applicable.

 

Section 4.10     Equity
Capitalization. As of the date hereof, the authorized capital of the Company consists of 520,000,000 shares of capital stock, of which
500,000,000 shares are designated common stock, par value $0.0001 per share, and 20,000,000 shares are undesignated preferred stock. As
of the date hereof, the Company had 107,022,536 shares of common stock outstanding and no shares of preferred stock outstanding.

 

The Common Shares are registered
pursuant to Section 12(b) of the Exchange Act and is currently listed on a Principal Market under the trading symbol “KULR.”
The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Shares under
the Exchange Act, delisting the Common Shares from the Principal Market, nor has the Company received any notification that the Commission
or the Principal Market is contemplating terminating such registration or listing. To the Company’s knowledge, it is in compliance
with all applicable listing requirements of the Principal Market.

 

    - 14 -

     

    

 

Section 4.11     Intellectual
Property Rights. The Company and its Subsidiaries own or possess adequate rights or licenses to use all material trademarks, trade
names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals,
governmental authorizations, trade secrets and rights, if any, necessary to conduct their respective businesses as now conducted, except
as would not cause a Material Adverse Effect. The Company and its Subsidiaries have not received written notice of any infringement by
the Company or its Subsidiaries of trademark, trade name rights, patents, patent rights, copyrights, inventions, licenses, service names,
service marks, service mark registrations, or trade secrets, except as would not cause a Material Adverse Effect. To the knowledge of
the Company, there is no claim, action or proceeding being made or brought against, or to the Company’s knowledge, being threatened
against the Company or its Subsidiaries regarding trademark, trade name, patents, patent rights, invention, copyright, license, service
names, service marks, service mark registrations, trade secret or other infringement; and, except as would not cause a Material Adverse
Effect, the Company is not aware of any facts or circumstances which might give rise to any of the foregoing.

 

Section 4.12     Employee
Relations. Neither the Company nor any of its Subsidiaries is involved in any labor dispute nor, to the knowledge of the Company or
any of its Subsidiaries, is any such dispute threatened, in each case which is reasonably likely to cause a Material Adverse Effect.

 

Section 4.13     Environmental
Laws. The Company and its Subsidiaries (i) have not received written notice alleging any failure to comply in all material respects
with all Environmental Laws (as defined below), (ii) have received all permits, licenses or other approvals required of them under
applicable Environmental Laws to conduct their respective businesses and (iii) have not received written notice alleging any failure
to comply with all terms and conditions of any such permit, license or approval where, in each of the foregoing clauses (i), (ii) and
(iii), the failure to so comply would be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect. The
term “Environmental Laws” means all applicable federal, state and local laws relating to pollution or protection of
human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata),
including, without limitation, laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants,
or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise
relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials,
as well as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses, notices or notice letters,
orders, permits, plans or regulations issued, entered, promulgated or approved thereunder.

 

Section 4.14     Title.
Except as would not cause a Material Adverse Effect, the Company (or its Subsidiaries) have indefeasible fee simple or leasehold title
to its properties and material assets owned by it, free and clear of any pledge, lien, security interest, encumbrance, claim or equitable
interest other than such as are not material to the business of the Company. Any real property and facilities held under lease by the
Company and its Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material
and do not interfere with the use made and proposed to be made of such property and buildings by the Company and its Subsidiaries.

 

    - 15 -

     

    

 

Section 4.15     Insurance.
The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks
and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the Company and its Subsidiaries
are engaged. The Company has no reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage
expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not have
a Material Adverse Effect.

 

Section 4.16     Regulatory
Permits. Except as would not cause a Material Adverse Effect, the Company and its Subsidiaries possess all material certificates,
authorizations and permits issued by the appropriate federal, state or foreign regulatory authorities necessary to own their respective
businesses, and neither the Company nor any such Subsidiary has received any written notice of proceedings relating to the revocation
or modification of any such certificate, authorization or permits.

 

Section 4.17     Internal
Accounting Controls. The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that
(i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are
recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting principles and to
maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific
authorization and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate
action is taken with respect to any differences, and management is not aware of any material weaknesses that are not disclosed in the
SEC Documents as and when required.

 

Section 4.18     Absence
of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency,
self-regulatory organization or body pending against or affecting the Company, the Common Shares or any of the Company’s Subsidiaries,
wherein an unfavorable decision, ruling or finding would have a Material Adverse Effect.

 

Section 4.19     Subsidiaries.
Except as disclosed in the SEC Documents, the Company does not presently own or control, directly or indirectly, any interest in any other
corporation, partnership, association or other business entity.

 

Section 4.20     Tax
Status. Except as would not have a Material Adverse Effect, each of the Company and its Subsidiaries (i) has timely made or filed
all foreign, federal and state income and all other tax returns, reports and declarations required by any jurisdiction to which it is
subject, (ii) has timely paid all taxes and other governmental assessments and charges that are material in amount, shown or determined
to be due on such returns, reports and declarations, except those being contested in good faith and (iii) has set aside on its books
provision reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations
apply. The Company has not received written notification any unpaid taxes in any material amount claimed to be due by the taxing authority
of any jurisdiction, and the officers of the Company and its Subsidiaries know of no basis for any such claim where failure to pay would
cause a Material Adverse Effect.

 

    - 16 -

     

    

 

Section 4.21     Certain
Transactions. Except as not required to be disclosed pursuant to Applicable Law, none of the officers or directors of the Company
is presently a party to any transaction with the Company (other than for services as employees, officers and directors), including any
contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property
to or from, or otherwise requiring payments to or from any officer or director, or to the knowledge of the Company, any corporation, partnership,
trust or other entity in which any officer or director has a substantial interest or is an officer, director, trustee or partner.

 

Section 4.22     Rights
of First Refusal. Except as disclosed in the SEC Documents, the Company is not obligated to offer the Common Shares offered hereunder
on a right of first refusal basis or otherwise to any third parties including, but not limited to, current or former shareholders of the
Company, underwriters, brokers, agents or other third parties.

 

Section 4.23     Dilution.
The Company is aware and acknowledges that issuance of Common Shares hereunder could cause dilution to existing shareholders and could
significantly increase the outstanding number of Common Shares.

 

Section 4.24     Acknowledgment
Regarding Investor’s Purchase of Shares. The Company acknowledges and agrees that the Investor is acting solely in the capacity
of an arm’s length investor with respect to this Agreement and the transactions contemplated hereunder. The Company further acknowledges
that the Investor is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement
and the transactions contemplated hereunder and any advice given by the Investor or any of its representatives or agents in connection
with this Agreement and the transactions contemplated hereunder is merely incidental to the Investor’s purchase of the Shares hereunder.
The Company is aware and acknowledges that it shall not be able to request Advances under this Agreement if the Registration Statement
is not effective or if any issuances of Common Shares pursuant to any Advances would violate any rules of the Principal Market. The
Company acknowledged and agrees that it is capable of evaluating and understanding, and understands and accepts, the terms, risks and
conditions of the transactions contemplated by this Agreement.

 

Section 4.25     Finder’s
Fees. Neither the Company nor any of the Subsidiaries has incurred any liability for any finder’s fees, brokerage commissions
or similar payments in connection with the transactions herein contemplated.

 

Section 4.26     Relationship
of the Parties. Neither the Company, nor any of its subsidiaries, affiliates, nor any person acting on its or their behalf is a client
or customer of the Investor or any of its affiliates and neither the Investor nor any of its affiliates has provided, or will provide,
any services to the Company or any of its affiliates, its subsidiaries, or any person acting on its or their behalf. The Investor’s
relationship to Company is solely as investor as provided for in the Transaction Documents.

 

    - 17 -

     

    

 

Section 4.27     Operations.
The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with and  neither
the Company nor the Subsidiaries, nor any director, officer, or employee of the Company or any Subsidiary nor, to the Company’s
knowledge, any agent, affiliate or other person acting on behalf of the Company or any Subsidiary has, not complied with Applicable Law;
and no action, suit or proceeding by or before any governmental authority involving the Company or any of its Subsidiaries with respect
to Applicable Laws is pending or, to the knowledge of the Company, threatened.

 

Section 4.28     Forward-Looking
Statements. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section 21E of the
Exchange Act) contained in the Registration Statement or a Prospectus has been made or reaffirmed without a reasonable basis or has been
disclosed other than in good faith.

 

Section 4.29     Compliance
with Laws. Except as would not have a Material Adverse Effect, the Company and each of its Subsidiaries are in compliance with Applicable
Laws; the Company has not received a notice of non-compliance, nor knows of, nor has reasonable grounds to know of, any facts that any
director, officer, or employee of the Company or any Subsidiary nor, to the Company’s knowledge, any agent, affiliate or other person
acting on behalf of the Company or any Subsidiary has, has not complied with Applicable Laws, or could give rise to a notice of non-compliance
with Applicable Laws, and is not aware of any pending change or contemplated change to any applicable law or regulation or governmental
position; in each case that would materially adversely affect the business of the Company or the business or legal environment under which
the Company operates.

 

Section 4.30     Sanctions
Matters. Neither the Company, nor any Subsidiary of the Company, nor, to the Company’s knowledge, any director, officer, agent,
employee or affiliate of the Company or any Subsidiary of the Company, is a Person that is, or is owned or controlled by a Person that
is:

 

		(a)	on the list of Specially Designated Nationals and Blocked Persons maintained by OFAC from time to time;

 

		(b)	the subject of any Sanctions; or

 

		(c)	has a place of business in, or is operating, organized, resident or doing business in a country or territory
that is, or whose government is, the subject of Sanctions Programs (including without limitation Crimea, Cuba, Iran, North Korea,
Sudan and Syria).

 

    - 18 -

     

    

 

Article V. Indemnification

 

The Investor and the Company
represent to the other the following with respect to itself:

 

Section 5.01     Indemnification
by the Company. In consideration of the Investor’s execution and delivery of this Agreement, and in addition to all of the Company’s
other obligations under this Agreement, the Company shall defend, protect, indemnify and hold harmless the Investor and its investment
manager, Yorkville Advisors Global, LP, and each of their respective officers, directors, managers, members, partners, employees and agents
(including, without limitation, those retained in connection with the transactions contemplated by this Agreement) and each person who
controls the Investor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act (collectively,
the “Investor Indemnitees”) from and against any and all actions, causes of action, suits, claims, losses, costs, penalties,
fees, liabilities and damages, and reasonable and documented expenses in connection therewith (irrespective of whether any such Investor
Indemnitee is a party to the action for which indemnification hereunder is sought), and including reasonable attorneys’ fees and
disbursements (the “Indemnified Liabilities”), incurred by the Investor Indemnitees or any of them as a result of,
or arising out of, or relating to (a) any untrue statement or alleged untrue statement of a material fact contained in the Registration
Statement for the registration of the Shares as originally filed or in any amendment thereof, or in any related prospectus, or in any
amendment thereof or supplement thereto, or arise out of or are based upon the omission or alleged omission to state therein a material
fact required to be stated therein or necessary to make the statements therein not misleading; provided, however, that the
Company will not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon
any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity
with written information furnished to the Company by or on behalf of the Investor specifically for inclusion therein; (b) any material
misrepresentation or breach of any material representation or material warranty made by the Company in this Agreement or any other certificate,
instrument or document contemplated hereby or thereby; or (c) any material breach of any material covenant, material agreement or
material obligation of the Company contained in this Agreement or any other certificate, instrument or document contemplated hereby or
thereby. To the extent that the foregoing undertaking by the Company may be unenforceable under Applicable Law, the Company shall make
the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities, which is permissible under Applicable
Law.

 

Section 5.02     Indemnification
by the Investor. In consideration of the Company’s execution and delivery of this Agreement, and in addition to all of the Investor’s
other obligations under this Agreement, the Investor shall defend, protect, indemnify and hold harmless the Company and all of its officers,
directors, shareholders, employees and agents (including, without limitation, those retained in connection with the transactions contemplated
by this Agreement) and each person who controls the Investor within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act (collectively, the “Company Indemnitees”) from and against any and all Indemnified Liabilities
incurred by the Company Indemnitees or any of them as a result of, or arising out of, or relating to (a) any untrue statement or
alleged untrue statement of a material fact contained in the Registration Statement for the registration of the Shares as originally filed
or in any amendment thereof, or in any related prospectus, or in any amendment thereof or supplement thereto, or arise out of or are based
upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements
therein not misleading; provided, however, that the Investor will only be liable for written information relating to the
Investor furnished to the Company by or on behalf of the Investor specifically for inclusion in the documents referred to in the foregoing
indemnity, and will not be liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based
upon any such untrue statement or alleged untrue statement or omission or alleged omission made therein in reliance upon and in conformity
with written information furnished to the Investor by or on behalf of the Company specifically for inclusion therein; (b) any misrepresentation
or breach of any representation or warranty made by the Investor in this Agreement or any instrument or document contemplated hereby or
thereby executed by the Investor; or (c) any breach of any covenant, agreement or obligation of the Investor(s) contained in
this Agreement or any other certificate, instrument or document contemplated hereby or thereby executed by the Investor. To the extent
that the foregoing undertaking by the Investor may be unenforceable under Applicable Law, the Investor shall make the maximum contribution
to the payment and satisfaction of each of the Indemnified Liabilities, which is permissible under Applicable Law.

 

    - 19 -

     

    

 

Section 5.03     Notice
of Claim. Promptly after receipt by an Investor Indemnitee or Company Indemnitee of notice of the commencement of any action or proceeding
(including any governmental action or proceeding) involving an Indemnified Liability, such Investor Indemnitee or Company Indemnitee,
as applicable, shall, if a claim for an Indemnified Liability in respect thereof is to be made against any indemnifying party under this
Article V, deliver to the indemnifying party a written notice of the commencement thereof; but the failure to so notify the indemnifying
party will not relieve it of liability under this Article V except to the extent the indemnifying party is prejudiced by such failure.
The indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any
other indemnifying party similarly noticed, to assume control of the defense thereof with counsel mutually reasonably satisfactory to
the indemnifying party and the Investor Indemnitee or Company Indemnitee, as the case may be; provided, however, that an Investor Indemnitee
or Company Indemnitee shall have the right to retain its own counsel with the actual and reasonable third party fees and expenses of not
more than one counsel for such Investor Indemnitee or Company Indemnitee to be paid by the indemnifying party, if, in the reasonable opinion
of counsel retained by the indemnifying party, the representation by such counsel of the Investor Indemnitee or Company Indemnitee and
the indemnifying party would be inappropriate due to actual or potential differing interests between such Investor Indemnitee or Company
Indemnitee and any other party represented by such counsel in such proceeding. The Investor Indemnitee or Company Indemnitee shall cooperate
fully with the indemnifying party in connection with any negotiation or defense of any such action or claim by the indemnifying party
and shall furnish to the indemnifying party all information reasonably available to the Investor Indemnitee or Company Indemnitee which
relates to such action or claim. The indemnifying party shall keep the Investor Indemnitee or Company Indemnitee reasonably apprised as
to the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any settlement
of any action, claim or proceeding effected without its prior written consent, provided, however, that the indemnifying party shall not
unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written consent of the Investor
Indemnitee or Company Indemnitee, consent to entry of any judgment or enter into any settlement or other compromise which does not include
as an unconditional term thereof the giving by the claimant or plaintiff to such Investor Indemnitee or Company Indemnitee of a release
from all liability in respect to such claim or litigation. Following indemnification as provided for hereunder, the indemnifying party
shall be subrogated to all rights of the Investor Indemnitee or Company Indemnitee with respect to all third parties, firms or corporations
relating to the matter for which indemnification has been made. The indemnification required by this Article V shall be made by periodic
payments of the amount thereof during the course of the investigation or defense, as and when bills are received and payment therefor
is due.

 

    - 20 -

     

    

 

Section 5.04     Remedies.
The remedies provided for in this Article V are not exclusive and shall not limit any right or remedy which may be available to
any indemnified person at law or equity. The obligations of the parties to indemnify or make contribution under this Article V shall
survive expiration or termination of this Agreement. Notwithstanding anything to the contrary under this Agreement or Applicable Law,
no party shall be entitled to any indemnification pursuant to this Article V (other than claims for any damages resulting from fraud)
until the aggregate amount of all such damages that would otherwise be indemnifiable to such party equals or exceeds $25,000 (the “Basket”),
at which time such party shall be entitled to indemnification for the full amount of all damages (including all damages incurred prior
to exceeding the Basket).

 

Section 5.05     Limitation
of liability. Notwithstanding the foregoing, no party shall be entitled to recover from the other party for punitive, indirect, incidental
or consequential damages.

 

Article VI.

Covenants of the Company

 

Section 6.01     Registration
Statement.

 

		(a)	The Company has filed a registration statement (with File Number 333-257697”Reg) (the “Initial
Registration Statement”) with the SEC under the Securities Act on Form S-3 with respect to the issuance and sale of securities
by the Company, including Common Stock, which contains, among other things a Plan of Distribution section disclosing the methods by which
the Company may sell the Common Stock. The Initial Registration Statement was declared effective on July 13, 2021 and remains in
effect on the date hereof.

 

		(b)	Promptly after the date hereof (and prior to the Company delivering an Advance Notice to the Investor
hereunder), the Company shall file with the SEC a report on Form 8-K or such other appropriate form as determined by counsel to the
Company, relating to the transactions contemplated by this Agreement and a Prospectus Supplement pursuant to Rule 424(b) of
the Securities Act disclosing all information relating to the transaction contemplated hereby required to be disclosed therein and an
updated Plan of Distribution, including, without limitation, the name of the Investor, if required, the number of Shares being offered
hereunder, the terms of the offering, the purchase price of the Shares, and other material terms of the offering, and any other information
or disclosure necessary to register the transactions contemplated herein (collectively, the “Initial Disclosure”) and
shall provide the Investor with 24 hours to review the Initial Disclosure prior to its filing.

 

    - 21 -

     

    

 

		(c)	Maintaining a Registration Statement. The Company shall maintain the effectiveness of any Registration
Statement with respect to the Shares at all times during the Commitment Period (the “Registration Period”), except
for any time during which the SEC reviews any successor Registration Statement, post-effective amendment to any Registration Statement,
prospectus supplement to any Registration Statement or other filing necessary to register the offer and sale of the Shares and resale
of the Shares. Notwithstanding anything to the contrary contained in this Agreement, the Company shall ensure that, when filed and at
all times while effective, each Registration Statement (including, without limitation, all amendments and supplements thereto) and the
prospectus (including, without limitation, all amendments and supplements thereto) used in connection with such Registration Statement
shall not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary
to make the statements therein (in the case of prospectuses, in the light of the circumstances in which they were made) not misleading.
During the Commitment Period, the Company shall notify the Investor promptly if (i) the Registration Statement shall cease to be
effective under the Securities Act, (ii) the Common Stock shall cease to be authorized for listing on the Principal Market, (iii) the
Common Stock ceases to be registered under Section 12(b) or Section 12(g) of the Exchange Act or (iv) the Company
fails to file in a timely manner all reports and other documents required of it as a reporting company under the Exchange Act.

 

		(d)	Filing Procedures. Not less than
                                            one business days prior to the filing of a Registration Statement and not less than one business
                                            day prior to the filing of any related amendments and supplements to any Registration Statements
                                            (except for any amendments or supplements caused by the filing of any annual reports on Form 10-K,
                                            quarterly reports on Form 10-Q, current reports on Form 8-K, and any similar or
                                            successor reports), the Company shall furnish to the Investor copies of all such documents
                                            proposed to be filed, which documents (other than those filed pursuant to Rule 424 promulgated
                                            under the Securities Act) will be subject to the reasonable and prompt review of the Investor
                                            (in each of which cases, if such document contains material non-public information as consented
                                            to by the Investor pursuant to Section 6.12, the information provided to Investor will
                                            be kept strictly confidential until filed and treated as subject to Section 6.08). The
                                            Investor shall furnish comments on a Registration Statement and any related amendment and
                                            supplement to a Registration Statement to the Company within 24 hours of the receipt thereof.
                                            If the Investor fails to provide comments to the Company within such 24-hour period, then
                                            the Registration Statement, related amendment or related supplement, as applicable, shall
                                            be deemed accepted by the Investor in the form originally delivered by the Company to the
                                            Investor.

 

		(e)	Delivery of Final Documents. The Company shall furnish to the Investor without charge, (i) at
least one copy of each Registration Statement as declared effective by the SEC and any amendment(s) thereto, including financial
statements and schedules, all documents incorporated therein by reference, all exhibits and each preliminary prospectus, (ii) at
the request of the Investor, at least one copy of the final prospectus included in such Registration Statement and all amendments and
supplements thereto (or such other number of copies as the Investor may reasonably request) and (iii) such other documents as the
Investor may reasonably request from time to time in order to facilitate the disposition of the Common Shares owned by the Investor pursuant
to a Registration Statement. Filing of the forgoing with the SEC via its EDGAR system shall satisfy the requirements of this section.

 

    - 22 -

     

    

 

		(f)	Amendments and Other Filings. The Company shall (i) prepare and file with the SEC such amendments (including
post-effective amendments) and supplements to a Registration Statement and the related prospectus used in connection with such Registration
Statement, which prospectus is to be filed pursuant to Rule 424 promulgated under the Securities Act, as may be necessary to keep
such Registration Statement effective at all times during the Commitment Period; (ii) cause the related prospectus to be amended
or supplemented by any required prospectus supplement (subject to the terms of this Agreement), and as so supplemented or amended to be
filed pursuant to Rule 424 promulgated under the Securities Act; (iii) provide the Investor copies of all correspondence from
and to the SEC relating to a Registration Statement (provided that the Company may excise any information contained therein which would
constitute material non-public information.

 

		(g)	Blue-Sky. The Company shall use its commercially reasonable efforts to, if required by Applicable
Law, (i) register and qualify the Common Shares covered by a Registration Statement under such other securities or “blue sky”
laws of such jurisdictions in the United States as the Investor reasonably requests, (ii) prepare and file in those jurisdictions,
such amendments (including post-effective amendments) and supplements to such registrations and qualifications as may be necessary to
maintain the effectiveness thereof during the Commitment Period, (iii) take such other actions as may be necessary to maintain such
registrations and qualifications in effect at all times during the Commitment Period, and (iv) take all other actions reasonably
necessary or advisable to qualify the Common Shares for sale in such jurisdictions; provided, however, that the Company shall not be required
in connection therewith or as a condition thereto to (w) make any change to its Articles of Incorporation or Bylaws, (x) qualify
to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section 6.01(f), (y) subject
itself to general taxation in any such jurisdiction, or (z) file a general consent to service of process in any such jurisdiction.
The Company shall promptly notify the Investor of the receipt by the Company of any notification with respect to the suspension of the
registration or qualification of any of the Common Shares for sale under the securities or “blue sky” laws of any jurisdiction
in the United States or its receipt of actual notice of the initiation or threat of any proceeding for such purpose.

 

Section 6.02     Suspension
of Registration Statement.

 

		(a)	Establishment of a Black Out Period. During the Commitment Period, the Company from time to time
may suspend the use of the Registration Statement by written notice to the Investor in the event that the Company determines in its sole
discretion in good faith that such suspension is necessary to (A) delay the disclosure of material nonpublic information concerning
the Company, the disclosure of which at the time is not, in the good faith opinion of the Company, in the best interests of the Company
or (B) amend or supplement the Registration Statement or prospectus so that such Registration Statement or prospectus shall not include
an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading (a “Black Out Period”).

 

    - 23 -

     

    

 

		(b)	No Sales by Investor During the Black Out Period. During such Black Out Period, the Investor agrees
not to sell any Common Shares of the Company.

 

		(c)	Limitations on the Black Out Period. The Company shall not impose
any Black Out Period that is longer than 30 days or in a manner that is more restrictive (including, without limitation, as to duration)
than the comparable restrictions that the Company may impose on transfers of the Company’s equity securities by its directors and
senior executive officers. In addition, the Company shall not deliver any Advance Notice during any Black Out Period. If the public announcement
of such material, nonpublic information is made during a Black Out Period, the Black Out Period shall terminate immediately after such
announcement, and the Company shall immediately notify the Investor of the termination of the Black Out Period.

 

Section 6.03     Listing
of Common Shares. As of each Advance Date, the Shares to be sold by the Company from time to time hereunder will have been registered
under Section 12(b) of the Exchange Act and approved for listing on the Principal Market, subject to official notice of issuance.

 

Section 6.04     Opinion
of Counsel. Prior to the date of the delivery by the Company of the first Advance Notice, the Investor shall have received an opinion
letter from counsel to the Company in form and substance reasonably satisfactory to the Investor.

 

Section 6.05     Exchange
Act Registration. The Company will file in a timely manner all reports and other documents required of it as a reporting company under
the Exchange Act and will not take any action or file any document (whether or not permitted by Exchange Act or the rules thereunder)
to terminate or suspend its reporting and filing obligations under the Exchange Act.

 

Section 6.06     Transfer
Agent Instructions. For any time while there is a Registration Statement in effect for this transaction, the Company shall (if required
by the transfer agent for the Common Shares) cause legal counsel for the Company to deliver to the transfer agent for the Common Shares
(with a copy to the Investor) instructions to issue Common Shares to the Investor free of restrictive legends upon each Advance if the
delivery of such instructions are consistent with Applicable Law.

 

Section 6.07     Corporate
Existence. The Company will use commercially reasonable efforts to preserve and continue the corporate existence of the Company during
the Commitment Period.

 

    - 24 -

     

    

 

Section 6.08     Notice
of Certain Events Affecting Registration; Suspension of Right to Make an Advance. The Company will promptly notify the Investor, and
confirm in writing, upon its becoming aware of the occurrence of any of the following events in respect of a Registration Statement or
related prospectus relating to an offering of Common Shares (in each of which cases the information provided to Investor will be kept
strictly confidential): (i) except for requests made in connection with SEC investigations disclosed in the SEC Documents, receipt
of any request for additional information by the SEC or any other Federal or state governmental authority during the period of effectiveness
of the Registration Statement or any request for amendments or supplements to the Registration Statement or related prospectus; (ii) the
issuance by the SEC or any other Federal governmental authority of any stop order suspending the effectiveness of the Registration Statement
or the initiation of any proceedings for that purpose; (iii) receipt of any notification with respect to the suspension of the qualification
or exemption from qualification of any of the Common Shares for sale in any jurisdiction or the initiation or written threat of any proceeding
for such purpose; (iv) the happening of any event that makes any statement made in the Registration Statement or related prospectus
or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires the making
of any changes in the Registration Statement, related prospectus or documents so that, in the case of the Registration Statement, it will
not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make
the statements therein not misleading, and that in the case of the related prospectus, it will not contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading, or of the necessity to amend the Registration Statement or supplement a related
prospectus to comply with the Securities Act or any other law; and (v) the Company’s reasonable determination that a post-effective
amendment to the Registration Statement would be appropriate; and the Company will promptly make available to the Investor any such supplement
or amendment to the related prospectus. The Company shall not deliver to the Investor any Advance Notice, and the Company shall not sell
any Shares pursuant to any pending Advance Notice (other than as required pursuant to Section 2.02(d)), during the continuation of
any of the foregoing events (each of the events described in the immediately preceding clauses (i) through (v), inclusive, a “Material
Outside Event”).

 

Section 6.09     Consolidation.
If an Advance Notice has been delivered to the Investor, then the Company shall not effect any consolidation of the Company with or into,
or a transfer of all or substantially all the assets of the Company to another entity before the transaction contemplated in such Advance
Notice has been closed in accordance with Section 2.02 hereof, and all Shares in connection with such Advance have been received
by the Investor.

 

Section 6.10     Market
Activities. The Company will not, directly or indirectly, take any action designed to cause or result in, or that constitutes or might
reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company under Regulation M
of the Exchange Act.

 

Section 6.11     Expenses.
The Company, whether or not the transactions contemplated hereunder are consummated or this Agreement is terminated, will pay all expenses
incident to the performance of its obligations hereunder, including but not limited to (i) the preparation, printing and filing of
the Registration Statement and each amendment and supplement thereto, of each prospectus and of each amendment and supplement thereto;
(ii) the preparation, issuance and delivery of any Shares issued pursuant to this Agreement, (iii) all fees and disbursements
of the Company’s counsel, accountants and other advisors (but not, for the avoidance doubt, the fees and disbursements of Investor’s
counsel, accountants and other advisors), (iv) the qualification of the Shares under securities laws in accordance with the provisions
of this Agreement, including filing fees in connection therewith, (v) the printing and delivery of copies of any prospectus and any
amendments or supplements thereto, (vi) the fees and expenses incurred in connection with the listing or qualification of the Shares
for trading on the Principal Market, or (vii) filing fees of the SEC and the Principal Market.

 

    - 25 -

     

    

 

Section 6.12     Current
Report. The Company shall not, and the Company shall cause each of its Subsidiaries and each of its and their respective officers,
directors, employees and agents not to, provide the Investor with any material, non-public information regarding the Company or any of
its Subsidiaries without the express prior written consent of the Investor (which may be granted or withheld in the Investor’s sole
discretion and if granted must include an agreement to keep such information confidential until publicly disclosed or 45 days have passed);
it being understood that the mere notification of Investor required pursuant to Section 6.08(iv) hereof shall not in and of
itself be deemed to be material non-public information. Notwithstanding anything contained in this Agreement to the contrary, the Company
expressly agrees that it shall publicly disclose, no later than four 45 days following the date hereof, but in any event prior to delivering
the first Advance Notice hereunder, any information communicated to the Investor by or, to the knowledge of the Company, on behalf of
the Company in connection with the transactions contemplated herein, which, following the date hereof would, if not so disclosed, constitute
material, non-public information regarding the Company or its Subsidiaries.

 

Section 6.13     Advance
Notice Limitation. The Company shall not deliver an Advance Notice if a shareholder meeting or corporate action date, or the record
date for any shareholder meeting or any corporate action, would fall during the period beginning two Trading Days prior to the date of
delivery of such Advance Notice and ending two Trading Days following the Closing of such Advance.

 

Section 6.14     Use
of Proceeds. The Company will use the proceeds from the sale of the Common Shares hereunder for working capital and other general
corporate purposes or, if different, in a manner consistent with the application thereof described in the Registration Statement. Neither
the Company nor any Subsidiary will, directly or indirectly, use the proceeds of the transactions contemplated herein, or lend, contribute,
facilitate or otherwise make available such proceeds to any Person (i) to fund, either directly or indirectly, any activities
or business of or with any Person that is identified on the list of Specially Designated Nationals and Blocker Persons maintained by OFAC,
or in any country or territory, that, at the time of such funding, is, or whose government is, the subject of Sanctions or Sanctions Programs,
or (ii) in any other manner that will result in a violation of Sanctions or Applicable Laws.

 

Section 6.15     Compliance
with Laws. The Company shall comply in all material respects with all Applicable Laws.

 

Section 6.16     Market
Activities. Neither the Company, nor any Subsidiary, nor any of their respective officers, directors or controlling persons will,
directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or might reasonably be expected to
constitute or result, in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale
of Common Shares or (ii) sell, bid for, or purchase Common Shares in violation of Regulation M, or pay anyone any compensation for
soliciting purchases of the Shares.

 

    - 26 -

     

    

 

Article VII.

Conditions for Delivery of Advance Notice

 

Section 7.01     Conditions
Precedent to the Right of the Company to Deliver an Advance Notice. The right of the Company to deliver an Advance Notice and the
obligations of the Investor hereunder with respect to an Advance is subject to the satisfaction by the Company, on each Advance Notice
Date (a “Condition Satisfaction Date”), of each, unless waived by the Investor, of the following conditions:

 

		(a)	Accuracy of the Company’s Representations and Warranties. The representations and warranties
of the Company in this Agreement shall be true and correct in all material respects.

 

		(b)	Registration of the Common Shares with the SEC. There is an effective Registration Statement pursuant
to which the Investor is permitted to utilize the prospectus thereunder to resell all of the Common Shares issuable pursuant to such Advance
Notice. The Company shall have filed with the SEC in a timely manner all reports, notices and other documents required under the Exchange
Act and applicable SEC regulations during the twelve-month period immediately preceding the applicable Condition Satisfaction Date.

 

		(c)	Authority. The Company shall have obtained all permits and qualifications required by any applicable
state for the offer and sale of all the Common Shares issuable pursuant to such Advance Notice, or shall have the availability of exemptions
therefrom. The sale and issuance of such Common Shares shall be legally permitted by all laws and regulations to which the Company is
subject.

 

		(d)	No Material Outside Event. No Material Outside Event shall have occurred and be continuing.

 

		(e)	Performance by the Company. The Company shall have performed, satisfied and complied in all material
respects with all covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company
at or prior the applicable Condition Satisfaction Date.

 

		(f)	No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall
have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits or
directly, materially and adversely affects any of the transactions contemplated by this Agreement.

 

		(g)	No Suspension of Trading in or Delisting of Common Shares. The Common Shares are quoted for trading
on the Principal Market and all of the Shares issuable pursuant to such Advance Notice will be listed or quoted for trading on the Principal
Market. The issuance of Common Shares with respect to the applicable Advance Notice will not violate the shareholder approval requirements
of the Principal Market. The Company shall not have received any written notice that is then still pending threatening the continued quotation
of the Common Shares on the Principal Market.

 

    - 27 -

     

    

 

		(h)	Authorized. There shall be a sufficient number of authorized but unissued and otherwise unreserved
Common Shares for the issuance of all of the Shares issuable pursuant to such Advance Notice.

 

		(i)	Executed Advance Notice. The representations contained in the applicable Advance Notice shall be
true and correct in all material respects as of the applicable Condition Satisfaction Date.

 

		(j)	Consecutive Advance Notices. Except with respect to the first Advance Notice, the Company shall
have delivered all Shares relating to all prior Advances, and at least 3 Trading Days shall have elapsed from the immediately preceding
Advance Date.

 

Article VIII.

Non-Disclosure of Non-Public Information

 

The Company covenants and agrees that, other than
as expressly required by Section 6.08 hereof, or, with the Investor’s consent pursuant to Section 6.01(d) and Section 6.12,
it shall refrain from disclosing, and shall cause its officers, directors, employees and agents to refrain from disclosing, any material
non-public information (as determined under the Securities Act, the Exchange Act, or the rules and regulations of the SEC) to the
Investor without also disseminating such information to the public, unless prior to disclosure of such information the Company identifies
such information as being material non-public information and provides the Investor with the opportunity to accept or refuse to accept
such material non-public information for review. Unless specifically agreed to in writing, in no event shall the Investor have a duty
of confidentiality, or be deemed to have agreed to maintain information in confidence, with respect to the delivery of any Advance Notices.

 

Article IX.

Non Exclusive Agreement

 

Notwithstanding anything contained
herein, this Agreement and the rights awarded to the Investor hereunder are non-exclusive, and the Company may, at any time throughout
the term of this Agreement and thereafter, issue and allot, or undertake to issue and allot, any shares and/or securities and/or convertible
notes, bonds, debentures, options to acquire shares or other securities and/or other facilities which may be converted into or replaced
by Common Shares or other securities of the Company, and to extend, renew and/or recycle any bonds and/or debentures, and/or grant any
rights with respect to its existing and/or future share capital.

 

Article X.

Choice of Law/Jurisdiction

 

This Agreement shall be governed
by and interpreted in accordance with the laws of the State of New York without regard to the principles of conflict of laws. The parties
further agree that any action between them shall be heard in New York County, New York, and expressly consent to the jurisdiction and
venue of the Supreme Court of New York, sitting in New York County, New York and the United States District Court of the Southern District
of New York, sitting in New York, New York, for the adjudication of any civil action asserted pursuant to this Agreement.

 

    - 28 -

     

    

 

Article XI. 

Assignment; Termination

 

Section 11.01     Assignment.
Neither this Agreement nor any rights or obligations of the parties hereto may be assigned to any other Person.

 

Section 11.02     Termination.

 

		(a)	Unless earlier terminated as provided hereunder, this Agreement shall terminate automatically on the earliest
of (i) the first day of the month next following the 24-month anniversary of the date hereof or (ii) the date on which the Investor
shall have made payment of Advances pursuant to this Agreement for Common Shares equal to the Commitment Amount.

 

		(b)	The Company may terminate this Agreement effective upon five (5) Trading Days’ prior written
notice to the Investor; provided that (i) there are no outstanding Advance Notices, the Common Shares under which have yet to be
issued, and (ii) the Company has paid all amounts owed to the Investor pursuant to this Agreement. This Agreement may be terminated
at any time by the mutual written consent of the parties, effective as of the date of such mutual written consent unless otherwise provided
in such written consent.

 

		(c)	Nothing in this Section 11.02 shall be deemed to release the Company or the Investor from any liability
for any breach under this Agreement, or to impair the rights of the Company and the Investor to compel specific performance by the other
party of its obligations under this Agreement. The indemnification provisions contained in Article V shall survive termination hereunder.

 

Article XII. 

Notices

 

Other than with respect to
Advance Notices, which must be in writing and will be deemed delivered on the day set forth in Section 2.01(b), any notices, consents,
waivers, or other communications required or permitted to be given under the terms of this Agreement must be in writing and will be deemed
to have been delivered (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile or e-mail if sent
on a Trading Day, or, if not sent on a Trading Day, on the immediately following Trading Day; (iii) five (5) calendar days after
being sent by U.S. certified mail, return receipt requested, (iv) 1 day after deposit with a nationally recognized overnight delivery
service, in each case properly addressed to the party to receive the same. The addresses and facsimile numbers for such communications
(except for Advance Notices which shall be delivered in accordance with Exhibit A hereof) shall be:

 

    - 29 -

     

    

 

	If to the Company, to:	
    KULR Technology Group, Inc.

    4863 Shawline Street

    San Diego, CA 92111

	 	Attention:  Michael Mo
	 	
    Telephone: (408) 663-5247

    Email: Michael.mo@kulrtechnology.com

    

	 	 
	
     With a copy to (which shall not

    constitute notice or delivery of process) to:
	 
	 	
    Sichenzia Ross Ference LLP

    1185 Avenue of the Americas, 31st Floor

    New York, NY 10036

    Attention: Jay Yamamoto

    Telephone: (212) 930-9700

    Email: jyamamotoo@srf.law

	 	
     

    

	If to the Investor(s):	YA II PN, Ltd.
	 	1012 Springfield Avenue
	 	Mountainside, NJ 07092
	 	Attention:	Mark Angelo
	 		Portfolio Manager
	 	Telephone:	(201) 985-8300 
	 	
    Email:
	mangelo@yorkvilleadvisors.com

    

	 	 
	
    With a Copy (which shall not

    constitute notice or delivery of process) to:
	
    David Gonzalez, Esq.

    1012 Springfield Avenue

    Mountainside, NJ 07092

	 	Telephone:	(201) 985-8300
	 	Email:	legal@yorkvilleadvisors.com

 

Either may change its information contained in
this Article XII by delivering notice to the other party as set forth herein.

 

Article XIII.

 Miscellaneous

 

Section 13.01     Counterparts.
This Agreement may be executed in identical counterparts, both which shall be considered one and the same agreement and shall become effective
when counterparts have been signed by each party and delivered to the other party. Facsimile or other electronically scanned and delivered
signatures, including by e-mail attachment, shall be deemed originals for all purposes of this Agreement.

 

    - 30 -

     

    

 

Section 13.02     Entire
Agreement; Amendments. This Agreement supersedes all other prior oral or written agreements between the Investor, the Company, their
respective affiliates and persons acting on their behalf with respect to the matters discussed herein, and this Agreement contains the
entire understanding of the parties with respect to the matters covered herein and, except as specifically set forth herein, neither the
Company nor the Investor makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this
Agreement may be waived or amended other than by an instrument in writing signed by the parties to this Agreement.

 

Section 13.03     Reporting
Entity for the Common Shares. The reporting entity relied upon for the determination of the trading price or trading volume of the
Common Shares on any given Trading Day for the purposes of this Agreement shall be Bloomberg, L.P. or any successor thereto. The written
mutual consent of the Investor and the Company shall be required to employ any other reporting entity.

 

Section 13.04     Structuring
Fee. Each of the parties shall pay its own fees and expenses (including the fees of any attorneys, accountants, appraisers or
others engaged by such party) in connection with this Agreement and the transactions contemplated hereby, except that the Company shall
pay YA Global II SPV, LLC, a subsidiary of the Investor, a structuring fee in the amount of $10,000.

 

Section 13.05     Brokerage.
Each of the parties hereto represents that it has had no dealings in connection with this transaction with any finder or broker who will
demand payment of any fee or commission from the other party. The Company on the one hand, and the Investor, on the other hand, agree
to indemnify the other against and hold the other harmless from any and all liabilities to any person claiming brokerage commissions or
finder’s fees on account of services purported to have been rendered on behalf of the indemnifying party in connection with this
Agreement or the transactions contemplated hereby.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    - 31 -

     

    

 

IN WITNESS WHEREOF,
the parties hereto have caused this Standby Equity Purchase Agreement to be executed by the undersigned, thereunto duly authorized, as
of the date first set forth above.

 

 

	 	COMPANY:
	 	KULR Technology Group, Inc.
	 	 
	 	By:	 
	 	Name: Michael Mo
	 	Title: CEO and Chairman 
	 	 
	 	 
	 	INVESTOR:
	 	YA II PN, Ltd.
	 	 
	 	By:	Yorkville Advisors Global, LP
	 	Its:	Investment Manager
	 	 	 
	 	
     
	By:         Yorkville Advisors Global II, LLC

    Its:         General Partner

    

	 	 	 
	 	 	By:	                 
	 	 	Name:
	 	 	Title:

 

    - 32 -

     

    

 

EXHIBIT A

ADVANCE NOTICE

 

KULR TECHNOLOGY GROUP, INC.

 

	Dated: ______________	 	Advance Notice Number: ____         

 

The undersigned, _______________________,
hereby certifies, with respect to the sale of Common Shares of KULR TECHNOLOGY GROUP, INC. (the
 “Company”) issuable in connection with this Advance Notice, delivered pursuant to that certain Standby Equity Purchase
Agreement, dated as of [____________] (the “Agreement”), as follows:

 

1.            The
undersigned is the duly elected ______________ of the Company.

 

2.            There
are no fundamental changes to the information set forth in the Registration Statement which would require the Company to file a post-effective
amendment to the Registration Statement.

 

3.            The
Company has performed in all material respects all covenants and agreements to be performed by the Company contained in this Agreement
on or prior to the Advance Notice Date. All conditions to the delivery of this Advance Notice are satisfied as of the date hereof.

 

4.            The
amount of the Advance the Company is requesting is _____________________.

 

5.            The
Minimum Acceptable Price with respect to this Advance Notice is _________ (if left blank then no Minimum Acceptable Price will be applicable
to this Advance).

 

6.            The
number of Common Shares of the Company outstanding as of the date hereof is ___________.

 

The undersigned has executed
this Advance Notice as of the date first set forth above.

 

	 	KULR TECHNOLOGY GROUP, INC.
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

 

Please deliver this Advance
Notice by email to:

Email: Trading@yorkvilleadvisors.com

Attention: Trading Department
and Compliance Officer

Confirmation Telephone Number:
(201) 985-8300.

 

    

     

    

 

EXHIBIT B

FORM OF SETTLEMENT DOCUMENT

 

VIA EMAIL

 

KULR TECHNOLOGY GROUP, INC.

Attn:

Email:

 

	 	Below please find the settlement information with respect to the Advance Notice Date of:	 
	1.	Advance requested in the Advance Notice	 
	2.	Minimum Acceptable Price for this Advance (if any)	 
	3.	Number of Excluded Days (if any)	 
	4.	Adjusted Advance Amount (after taking into account any adjustments pursuant to Section 2.01):	 
	5.	Market Price	 
	6.	Purchase Price (Market Price x 98%) per share	 
	7.	Number of Shares due to Investor	 
	8.	Additional amount to be paid to the Company by the Investor (Additional Shares in number 8 x Minimum Acceptable Price)	 
	9.	Total Amount to be paid to Company (Purchase Price in number 6 + Additional amount in number 8):	 
	10.	Total Shares to be issued to Investor (Shares due to Investor in number 7 + Additional Shares in number 8):	 
	 	Total Shares to be issued to Investor (Shares due to Investor in number 7 + Additional Shares in number 8):	 

 

Please issue the number of Shares due to the Investor to the account of the Investor as follows:

 

Investor’s DTC participant
#:

 

ACCOUNT NAME:

ACCOUNT NUMBER:

ADDRESS:

CITY:

COUNTRY:

Contact person:

Number and/or email:

 

	 	Sincerely,
	 	 
	 	YA II PN, LTD.

 

    

     

    

 

Agreed and approved By KULR TECHNOLOGY GROUP, INC.:

 

 

	 	 
	Name:	 
	Title:Exhibit 10.2

 

EXECUTION VERSION

 

NOTE PURCHASE AGREEMENT

 

THIS NOTE PURCHASE AGREEMENT
(this “Agreement”) is dated as of May 13, 2022, by and between KULR TECHNOLOGY GROUP, INC., a corporation
organized and existing under the laws of the State of Delaware (the “Company”), and YAII PN, LTD., a Cayman
Islands exempt limited partnership (the “Investor”).

 

WITNESSETH

 

WHEREAS, the parties
desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to the Investor, as provided
herein, and the Investor shall purchase a full recourse promissory note in the form attached hereto as “Exhibit A”
(the “Note”) in the original principal amount of $5,000,000 (the “Original Principal Amount”);

 

WHEREAS, the issuance
and sale of a Note shall take place at a closing (the “Closing”) to take place within 1 trading day of the date hereof,
or such other date as may be agreed upon between the parties;

 

NOW, THEREFORE, in
consideration of the mutual covenants and other agreements contained in this Agreement, the Company and the Investor hereby agree as follows:

 

1.            CERTAIN
DEFINITIONS.

 

(a)            “Anti-Bribery
Laws” shall mean of any provision of any applicable law or regulation implementing the OECD Convention on Combating Bribery
of Foreign Public Officials in International Business Transactions or any applicable provision of the U.S. Foreign Corrupt Practices Act
of 1977, as amended (the “FCPA”), the U.K. Bribery Act 2010, or any other similar law of any other jurisdiction in
which the Company operates its business, including, in each case, the rules and regulations thereunder.

 

(b)            “Anti-Money
Laundering Laws” shall mean applicable financial recordkeeping and reporting requirements and all other applicable U.S. and
non-U.S. anti-money laundering laws, rules and regulations, including, but not limited to, those of the Currency and Foreign Transactions
Reporting Act of 1970, as amended, the United States Bank Secrecy Act, as amended by the USA PATRIOT Act of 2001, and the United States
Money Laundering Control Act of 1986 (18 U.S.C. §§1956 and 1957), as amended, as well as the implementing rules and regulations
promulgated thereunder, and the applicable money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder
and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency or self-regulatory.

 

    

     

    

 

(c)            “Applicable
Laws” shall mean applicable laws, statutes, rules, regulations, orders, executive orders, directives, policies, guidelines and
codes having the force of law, whether local, national, or international, as amended from time to time, including without limitation (i) Anti-Money
Laundering Laws and all applicable laws that relate to money laundering, terrorist financing, financial record keeping and reporting,
(ii) Anti-Bribery Laws and applicable laws that relate to anti-bribery, anti-corruption, books and records and internal controls,
(iii) OFAC and any Sanctions or Sanctions Programs, and (iv) CAATSA and any CAATSA Sanctions Programs.

 

(d)            “CAATSA”
shall mean Public Law No. 115-44 The Countering America’s Adversaries Through Sanctions Act.

 

(e)            “CAATSA
Sanctions Programs” shall mean a country or territory that is, or whose government is, the subject of sanctions imposed by CAATSA.

 

(f)

 

(g)            “OFAC”
shall mean the U.S. Department of Treasury’s Office of Foreign Asset Control.

 

(h)            “Person”
shall mean an individual, a corporation, a partnership, an association, a trust or other entity or organization, including a government
or political subdivision or an agency or instrumentality thereof.

 

(i)            “Sanctions”
shall mean any sanctions administered or enforced by OFAC or the U.S. Departments of State or Commerce and including, without limitation,
the designation as a “Specially Designated National” or on the “Sectoral Sanctions Identifications List”, collectively
 “Blocked Persons”), the United Nations Security Council (“UNSC”), the European Union, Her Majesty's Treasury
(“HMT”) or any other relevant sanctions authority

 

(j)            “Sanctioned
Country” shall mean a country or territory that is the subject or target of a comprehensive embargo or Sanctions Laws prohibiting
trade with the country or territory, including, without limitation, Crimea, Cuba, Iran, North Korea, Sudan and Syria.

 

(k)            “Sanctions
Programs” shall mean any OFAC, HMT or UNSC economic sanction program including, without limitation, programs related to a Sanctioned
Country.

 

2.            PURCHASE
AND SALE OF NOTES;

 

(a)            Purchase
of Note at the Closing. Subject to the satisfaction (or waiver) of the terms and conditions of this Agreement, the Investor agrees
to purchase at the Closing and the Company agrees to sell and issue to the Investor at the Closing a Note in the original principal amount
of $5,000,000 (the “Original Principal Amount”) for a purchase price equal to Original Principal Amount less any original
issue discounts and fees.

 

(b)            Closing
Deliverables. At the Closing, the following transactions shall occur and shall be deemed to take place simultaneously. No transaction
shall be deemed to have been completed or any document delivered until all such transactions have been completed and all required documents
have been delivered, unless waived in writing by the receiving Party: (i) the Company shall deliver, or cause to be delivered, to
the Investor a duly executed Note in the face amount of the Original Principal Amount and the Investor shall pay to the Company the Original
Principal Amount of the Note issued to the Inventor (less the fees and original issue discounts in Section 9 (a) herein) by
wire transfer to the account of the Company as specified on Schedule I to the Note.

 

    2

     

    

 

3.            Conditions
Precedent to Closing. The obligation of the Investor hereunder to purchase the Note at the Closing is subject to the satisfaction,
at or before the date of the Closing, of each of the following conditions, provided that these conditions are for the Investor’s
sole benefit and may be waived by the Investor at any time in its sole discretion.

 

(a)            The
Representations and Warranties of the Company are true and correct.

 

(b)            No
event shall have occurred since the date of this Agreement that could result in, or reasonably be expected to result in a Material Adverse
Effect, where “Material Adverse Effect” shall mean any condition, circumstance, or situation that may result in, or would
reasonably be expected to result in (i) a material adverse effect on the legality, validity or enforceability of this Agreement or
the Note, (collectively, the “Transaction Documents”), (ii) a material adverse effect on the results of operations,
assets, business, prospects or condition (financial or otherwise) of the Company, or (iii) a material adverse effect on the Company
or it’s ability to perform in any material respect on a timely basis its obligations under any Transaction Document.

 

(c)            The
shares of the Company’s common stock (the “Common Stock”) shall be authorized for quotation or trading on the
NYSE American (the “Primary Market”) and trading in the common stock of the Company shall not have been suspended for
any reason.

 

(d)            The
Company is, and has been for a period of at least 90 days immediately prior to the Closing, subject to the reporting requirements of section
13 or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”).

 

(e)            The
Standby Equity Purchase Agreement dated May 13, 2022 between the Company and the Investor (the “SEPA”) is in full
force and effect.

 

(f)            The
Company’s registration statement on Form S-3 (File No. 333-257697) under Section 5 of the Securities Act of 1933,
as amended, and the rules and regulations promulgated thereunder (the “Securities Act”) or another registration
statement on a form promulgated by the SEC for which the Company then qualifies for the registration of the offer and sale of securities
to be offered and sold by the Company, as the same may be amended and supplemented from time to time and including any information deemed
to be a part thereof pursuant to Rule 430B under the Securities Act and any successor registration statement filed by the Company
with the SEC under the Securities Act on a form promulgated by the SEC for which the Company then qualifies and which form shall be available
for the registration of securities to be offered and sold by the Company, shall be effective (collectively the “Registration
Statement”).

 

    3

     

    

 

4.            INVESTOR’S
REPRESENTATIONS AND WARRANTIES. Investor hereby represents and warrants to, and agrees with, the Company that the following are true
and correct as of the date hereof and as of the date of the Closing:

 

(a)            Organization
and Authorization. The Investor is duly organized, validly existing and in good standing under the laws of the Cayman Islands and
has all requisite power and authority to purchase, hold and sell the Note. The decision to invest and the execution and delivery of this
Agreement by such Investor, the performance by such Investor of its obligations hereunder and the consummation by such Investor of the
transactions contemplated hereby have been duly authorized and requires no other proceedings on the part of the Investor. The undersigned
has the right, power and authority to execute and deliver this Agreement and all other instruments on behalf of the Investor. This Agreement
has been duly executed and delivered by the Investor and, assuming the execution and delivery hereof and acceptance thereof by the Company,
will constitute the legal, valid and binding obligations of the Investor, enforceable against the Investor in accordance with its terms.

 

(b)            Evaluation
of Risks. The Investor has such knowledge and experience in financial, tax and business matters as to be capable of evaluating the
merits and risks of, and bearing the economic risks entailed by, an investment in the Company and of protecting its interests in connection
with this transaction. It recognizes that its investment in the Company involves a high degree of risk.

 

(c)            No
Legal Advice from the Company. The Investor acknowledges that it had the opportunity to review this Agreement and the transactions
contemplated by this Agreement with its own legal counsel and investment and tax advisors. The Investor is relying solely on such counsel
and advisors and not on any statements or representations of the Company or any of the Company’s representatives or agents for legal,
tax or investment advice with respect to this investment, the transactions contemplated by this Agreement or the securities laws of any
jurisdiction.

 

(d)            Investment
Purpose. The Note is being purchased by the Investor for its own account, and for investment purposes. The Investor agrees not to
assign or in any way transfer the Investor’s rights to the Note or any interest therein other than to affiliates of the Investor.
Except for affiliates of the Investor, no other Person has or will have a direct or indirect beneficial interest in the Commitment Fee
Shares.

 

(e)            Accredited
Investor. The Investor is an “Accredited Investor” as that term is defined in Rule 501(a)(3) of Regulation
D of the Securities Act of 1933.

 

(f)            Information.
The Investor and its advisors (and its counsel), if any, have been furnished with all materials relating to the business, finances and
operations of the Company and information it deemed material to making an informed investment decision. The Investor and its advisors,
if any, have been afforded the opportunity to ask questions of the Company and its management. Neither such inquiries nor any other due
diligence investigations conducted by such Investor or its advisors, if any, or its representatives shall modify, amend or affect the
Investor’s right to rely on the Company’s representations and warranties contained in this Agreement. The Investor understands
that its investment involves a high degree of risk.

 

(g)            No
General Solicitation. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has engaged in
any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection with
the offer or sale of the Note offered hereby.

 

    4

     

    

 

(h)            Not
an Affiliate. The Investor is not an officer, director or a person that directly, or indirectly through one or more intermediaries,
controls or is controlled by, or is under common control with the Company or any “Affiliate” of the Company (as that
term is defined in Rule 405 of the Securities Act).

 

5.            COMPANY’S
REPRESENTATIONS AND WARRANTIES. The Company hereby represents and warrants to, the Investor that the following are true and correct
as of the date hereof:

 

(a)            Organization
and Qualification. The Company is duly incorporated, validly existing and in good standing under the laws of the State of Delaware
and has all requisite corporate power to own its properties and to carry on its business as now being conducted. The Company and its subsidiaries
are duly qualified to do business and is in good standing (to the extent applicable) in every jurisdiction in which the nature of the
business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified or be in good standing
would not have a Material Adverse Effect.

 

(b)            Authorization,
Enforcement, Compliance with Other Instruments. (i) The Company has the requisite corporate power and authority to enter into
and perform this Agreement, the Note, and any related agreements, in accordance with the terms hereof and thereof, (ii) the execution
and delivery of this Agreement, the Note, and any related agreements by the Company and the consummation by it of the transactions contemplated
hereby and thereby, have been duly authorized by the Company’s Board of Directors and no further consent or authorization is required
by the Company, its Board of Directors or its shareholders, (iii) this Agreement, the Note, and any related agreements have been
duly executed and delivered by the Company, (iv) this Agreement and assuming the execution and delivery thereof and acceptance by
the Investor, the Note, and any related agreements, constitute the valid and binding obligations of the Company enforceable against the
Company in accordance with their terms, except as such enforceability may be limited by general principles of equity or applicable bankruptcy,
insolvency, reorganization, fraudulent transfer, moratorium, liquidation or similar laws from time to time relating to, or affecting generally,
the enforcement of creditors’ rights and remedies.

 

(c)            No
Conflict. The execution, delivery and performance of this Agreement and the Transaction Documents by the Company and the consummation
by the Company of the transactions contemplated hereby will not (i) result in a violation of its Articles of Association or Memorandum
of Association or (ii) conflict with or constitute a default (or an event which with notice or lapse of time or both would become
a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or
instrument to which the Company or any of its subsidiaries is a party, or result in a violation of any law, rule, regulation, order, judgment
or decree (including federal and state securities laws and regulations and the rules and regulations of the Primary Market on which
the Common Stock is quoted) applicable to the Company or any of its subsidiaries or by which any material property or asset of the Company
is bound or affected and which would cause a Material Adverse Effect. Neither the Company nor its subsidiaries is in violation of any
term of or in default under its Articles of Association or Memorandum of Association, or, to the Company’s knowledge, any material
contract, agreement, mortgage, indebtedness, indenture, instrument, judgment, decree or order or any statute, rule or regulation
applicable to the Company or its subsidiaries that would cause a Material Adverse Effect. To the Company’s knowledge, the business
of the Company and its subsidiaries is not being conducted in violation of any material law, ordinance or regulation of any governmental
entity, except as would not cause a Material Adverse Effect.

 

    5

     

    

 

(d)            Internal
Accounting Controls. The Company and each of its subsidiaries maintain a system of internal accounting controls sufficient to provide
reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations,
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with generally accepted accounting
principles and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general
or specific authorization and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals
and appropriate action is taken with respect to any differences.

 

(e)            Absence
of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency,
self-regulatory organization or body pending against or affecting the Company, its Common Stock or any of the Company’s subsidiaries,
wherein an unfavorable decision, ruling or finding would have a Material Adverse Effect.

 

(f)            Compliance
with Applicable Laws. The operations of the Company and its subsidiaries are and have been conducted, in all material respects and
at all times in compliance with Applicable Laws and no action, suit or proceeding by or before any court or governmental agency, authority
or body or any arbitrator involving the Company or any of its ssubsidiaries with respect to Applicable Laws is pending or, to the knowledge
of the Company, threatened.

 

(g)            Subsidiaries.
Other than as disclosed in the Company’s reports, schedules, forms, statements and other documents filed by it with the SEC pursuant
to Section 15(d) of the Exchange Act and documents incorporated by reference therein (the “SEC Documents”)
the Company does not presently own or control, directly or indirectly, any interest in any other corporation, partnership, association
or other business entity.

 

(h)            Tax
Status. The Company and each of its subsidiaries have made or filed all federal and state income and all other tax returns, reports
and declarations required by any jurisdiction to which it is subject to be filed as of the date hereof (unless and only to the extent
that the Company and each of its subsidiaries has set aside on its books provisions reasonably adequate for the payment of all unpaid
and unreported taxes) and has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined
to be due on such returns, reports and declarations, except those being contested in good faith and has set aside on its books provision
reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations
apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the officers
of the Company know of no basis for any such claim. Certain Transactions. None of the officers or directors of the Company is presently
a party to any transaction with the Company (other than for services as employees, officers and directors), including any contract, agreement
or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from,
or otherwise requiring payments to or from any officer or director, or to the knowledge of the Company, any corporation, partnership,
trust or other entity in which any officer or director has a substantial interest or is an officer, director, trustee or partner.

 

    6

     

    

 

(i)            No
General Solicitation. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has engaged in
any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection with
the offer or sale of the Commitment Fee Shares.

 

6.            COVENANTS
OF THE COMPANY.

 

(a)     Effectiveness
of the Registration Statement.     While any amounts are due and outstanding under the Note the Company
shall maintain the effectiveness of the Registration Statement, except for any time during which the SEC reviews any successor Registration
Statement, post-effective amendment to any Registration Statement, prospectus supplement to any Registration Statement or other filing
necessary to register securities to be offered and sold by the Company.

 

(b)            Use
of Proceeds. The Company will use the proceeds from the Note for working capital and other general corporate purposes. Neither the
Company nor any Subsidiary will, directly or indirectly, use the proceeds of the transactions contemplated herein, or lend, contribute,
facilitate or otherwise make available such proceeds to any Person (i) to fund, either directly or indirectly, any activities
or business of or with any Person that is identified on the list of Specially Designated Nationals and Blocked Persons maintained by OFAC,
or in any country or territory, that, at the time of such funding, is, or whose government is, the subject of Sanctions or Sanctions Programs,
(iv) or in any manner or in a country or territory, that, at the time of such funding, is, or whose government is, the subject of
CAATSA or CAATSA Sanctions Programs or (iv) in any other manner that will result in a violation of Applicable Laws.

 

(c)            Compliance
with Laws. While any amounts are due and outstanding under the Note the Company shall comply, in all material respects, with all Applicable
Laws and will not take any action which will cause the Investor to be in violation of any such Applicable Laws.

 

The covenants set forth above shall be ongoing
during the term of the Note. The Company shall promptly notify the Investor in writing should it become aware during such period (a) of
any changes to these covenants, or (b) if it cannot comply with the covenants set forth herein. The Company shall also promptly notify
the Investor in writing during such period should it become aware of an investigation, litigation or regulatory action relating to an
alleged or potential violation of Applicable Laws. The Company shall provide such information and documentation it may have as the Investor
or any of their affiliates may reasonably request to satisfy compliance with Applicable Laws.

 

    7

     

    

 

(d)           Restrictions
on Issuance of Capital Stock. Except with respect of an Exempt Issuance, so long as the Note is outstanding, the Company shall not, without
the prior written consent of the Investor, (i) issue or sell shares of Common Stock or Preferred Stock without consideration or
for a consideration per share less than the bid price of the Company’s common stock, as quoted by Bloomberg, LP, and determined
immediately prior to its issuance, (ii) issue any preferred stock, warrant, option, right, contract, call, or other security or
instrument granting the holder thereof the right to acquire Common Stock without consideration or for a consideration less than the bid
price of the Company’s common stock, as quoted by Bloomberg, LP and determined immediately prior to its issuance, (vi) enter
into any security instrument granting the holder a security interest in any and all assets of the Company, or (vii) other than for
bona-fide employee stock option plans, file any registration statement on Form S-8.
For purposes of this section, “Exempt Issuance” shall mean the issuance of (a) shares of Common Stock or
options to consultants, employees, officers or directors of the Company pursuant to any bonafide stock or option plan established for
such purpose for services rendered to the Company; (b) securities upon the exercise or exchange of or conversion of any securities
issued hereunder and/or other securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding
on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number
of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other than in connection
with stock splits or combinations) or to extend the term of such securities; (c) securities issued pursuant to acquisitions or strategic
transactions approved by a majority of the disinterested directors of the Company, provided that such securities are issued as “restricted
securities” (as defined in Rule 144) and carry no registration rights that require or permit the filing of any registration
statement in connection therewith during the prohibition period in this section, and provided that any such issuance shall only be to
a Person (or to the equity holders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an
asset in a business synergistic with the business of the Company and shall provide to the Company additional benefits, including the
investment of funds; and (d) any securities issued in connection with the SEPA.

 

7.            GOVERNING
LAW. This Agreement shall be governed by and interpreted in accordance with the laws of the State of New Jersey without regard to
the principles of conflict of laws. Each of the parties consents to the jurisdiction of the of the Superior Court of the State of New
Jersey, sitting in Union County, New Jersey and the United States District Court for the District of New Jersey, sitting in Newark, New
Jersey for the adjudication of any civil action asserted pursuant to this Agreement.

 

    8

     

    

 

8.            NOTICES.
Any notices, consents, waivers or other communications required or permitted to be given under the terms hereof must be in writing and
will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile
(provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party); or (iii) one
(1) Business Day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party
to receive the same. The addresses and facsimile numbers for such communications shall be:

 

	
     If to the Company, to:
	
     Kulr Technology Group, Inc.

	 	4863 Shawline Street 
	 	San Diego, CA 92111
	 	Attention:        Michael Mo, CEO
	 	Telephone:      (408) 663-5247
	 	Email:  michael.mo@kulrtechnology.com

 

	With a copy to:	Sichenzia Ross Ference LLP
	 	1185 Avenue of the Americas, 31st Floor
	 	New York, NY 10036
	 	Attention:        Jay Yamamoto, Esq.
	 	Telephone:      (212) 930-9700
	 	Email: jyamamoto@srf.law

 

 

	
     If to the Holder:
	
     YAII PN, Ltd.

	 	1012 Springfield Avenue
	 	Mountainside, NJ  07092
	 	Attention:       Mark Angelo
	 	
    Telephone:     (201) 985-8300

    Facsimile:        (201) 985-8266

	 	Email:               mangelo@yorkvilleadvisors.com
	 	 
	With a copy to:	David Gonzalez, Esq. 
	 	1012 Springfield Avenue
	 	Mountainside, NJ  07092
	 	Telephone:      (201) 985-8300
	 	
    Facsimile:         (201) 985-8266

    Email:                dgonzalez@yorkvilleadvisors.com

 

or at such other address and/or facsimile number
and/or to the attention of such other person as the recipient party has specified by written notice given to each other party three Business
Days prior to the effectiveness of such change. Written confirmation of receipt (i) given by the recipient of such notice, consent,
waiver or other communication, (ii) mechanically or electronically generated by the sender’s facsimile machine containing the
time, date, recipient facsimile number and an image of the first page of such transmission or (iii) provided by a nationally
recognized overnight delivery service, shall be rebuttable evidence of personal service, receipt by facsimile or receipt from a nationally
recognized overnight delivery service in accordance with clause (i), (ii) or (iii) above, respectively.

 

9.            MISCELLANEOUS.

 

(a)            Original
Issue Discount. The Original Principal Amount of the Note shall have an original issue discount of 5% (the “OID”) that
the Investor shall be entitled to deduct from the gross proceeds of the original Principal Amount when the Note is issued.

 

    9

     

    

 

(b)            Counterparts.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party.

 

(c)            Entire
Agreement; Amendments. This Agreement and the exhibit thereto supersedes all other prior oral or written agreements between the Investor
and the Company with respect to the matters discussed herein), and this Agreement and the exhibit theretocontain the entire understanding
of the parties with respect to the matters covered herein and therein. No provision of this Agreement may be waived or amended other than
by an instrument in writing signed by the party to be charged with enforcement.

 

(d)            Binding
Effect. All of the covenants and obligations contained herein shall be binding upon and shall inure to the benefit of the respective
parties, their successors and assigns.

 

(e)            Enforcement
Costs. The Company shall reimburse the Investor promptly for all out-of-pocket fees, costs and expenses, including, without limitation,
reasonable attorneys’ fees and expenses incurred by the Investor in any action for the collecting of any sums which become due and
payable to the Investor in accordance with the terms of this Agreement or the Note.

 

(f)            Remedies
Cumulative. No remedy herein conferred upon any party is intended to be exclusive of any other remedy, and each and every such remedy
shall be cumulative and shall be in addition to every other remedy given hereunder or now or hereafter existing at law, in equity, by
statute, or otherwise. No single or partial exercise by any party of any right, power or remedy hereunder shall preclude any other or
further exercise thereof.

 

(g)            Severability.
If any provision of this Agreement is, for any reason, invalid or unenforceable, the remaining provisions of this Agreement will nevertheless
be valid and enforceable and will remain in full force and effect. Any provision of this Agreement that is held invalid or unenforceable
by a court of competent jurisdiction will be deemed modified to the extent necessary to make it valid and enforceable and as so modified
will remain in full force and effect.

 

(h)            Waiver
of Jury Trial. THE PARTIES HEREBY KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVE THE RIGHT ANY OF THEM MAY HAVE TO A TRIAL BY
JURY IN RESPECT OF ANY LITIGATION BASED HEREON OR ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS AGREEMENT OR ANY COURSE OF CONDUCT,
COURSE OF DEALING, STATEMENTS (WHETHER VERBAL OR WRITTEN) OR ACTIONS OF ANY PARTY. THIS PROVISION IS A MATERIAL INDUCEMENT FOR THE PARTIES’
ACCEPTANCE OF THIS AGREEMENT.

 

[signature page follows]

 

    10

     

    

 

IN WITNESS WHEREOF,
each of the Investor and the Company have caused their respective signature page to this Note Purchase Agreement to be duly executed
as of the date first written above.

 

	 	COMPANY:
	 	 
	 	KULR TECHNOLOGY GROUP, INC.
	 	 
	 	By:	 
	 	Name:	Michael Mo
	 	Title:	Chief Executive Officer and Chairman
	 	 	 
	 	INVESTOR: 
	 	 
	 	YAII PN, LTD.
	 	 
	 	By:	Yorkville Advisors Global LP
	 	Its:	Investment Manager
	 	 	 
	 	By:	Yorkville Advisors Global II LLC
	 	Its:	General Partner
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 

 

    11

     

    

 

Exhibit A

Form of Note

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00344-of-00352.parquet"}]]